The Motherload of "rare" Serious/Severe Adverse events from the Covid-19 Bio Weapons

How much more proof do you need that these are NOT SAFE? Or EFFECTIVE?

On Jan 5, 2022, saveusnow.org.uk put out 1000+ studies regarding “Covid Vaccine Scientific Proof Lethal”. On first pass, it was overwhelming and informative as I was missing a piece for my jab info for the GlobalFrontlineNurses website that I manage and am responsible for the research.

However, I wasn’t a fan of the layout - no dates, no categories, dead links, duplicate links etc. I was hoping that they would compare it to the FDA VRBPAC meetings which were supposed to be on the manufacturers asses to ensure that safety would still be a “thing” since we skipped animals trials, merged the trial phases and unblinded the “placebo group”.. Speaking of the placebo group, am I the only one who finds it strange that so many people in said group were experiencing such a wide array of adverse events? Isn’t supposed to be saline? If so, how could so many people have an adverse to saline? Perhaps I’ll do a deep dive into that someday.

In any event, back to the matter at hand - the lack of safety for these bioweapons. At first, I thought it would take a couple of days correcting errors, adding a few newer studies or missed groups, etc. Big mistake, like HUGE MISTAKE. I had no idea how severe it really was, nor did I realize the amount of rabbit holes and cross-referencing I would get myself in.

Additional links and categories were added to make this the MOTHERLOAD. I made it as current as possible and will upload more when they become available.

Thanks to Danny Davies for sharing this with me. Actually screw that, you owe me a bottle of tequila or scotch dude ;)

I dedicate this, to those who have lost someone from the bioweapons or who have been injured as a result of the bioweapons.

This may be my final research effort and it is the most important “FU” to the “Health Powers Which Shouldn’t Be” who have not only violated informed consent for those who thought it wise to get injected/were forced to get injected/those who are around those who got injected/etc. Yes, shedding is a “thing” and has been for a few decades. Remember, just because you haven’t been injured or died, yet, doesn’t mean it won’t happen sooner because “you were doing your part”. The animals from past Rona trials would agree but they are all dead. :( VAERS is an absolute joke and allegedly they only have 50 people looking after the millions - hundreds of millions of Severe/Serious Adverse events. Yes, you read that correctly.

OK OWEN» FOCUS» ;)

The following, along with my research into the ingredients of the mRNA jabs, the negative-efficacy issue and other research I will eventually post here, should end the debate and put an immediate stop to the madness. I need your help getting this out.

As a reminder, I’ve included the FDA’s VRBPAC Meetings since Oct 22, 2020 onward for reference. Don’t freak out when you see how many studies/reports/etc. were mentioned as far back as Oct 22, 2020

THEN FEB 2021

THEN JUNE 2021

I just found this little gem which should have you scratching your heads.. From 2014, no less. :(

source

Looks like the lipid nanoparticle (LNP) has some explaining to do. I wonder how many issues below are linked with the above pic?

There are a couple of questions you must be asking yourself if your read the above.
1. What condition does not cause a serious/severe adverse event if you take he bioweapon?
2. Why would a positive “convid test" potentially cause an S/SAE?
3. Why would their be manufacturing issues when the standards are so high? ok this one is meant to be sarcastic but come on..

Let us take a look at the actual evidence now, shall we? These are a mixture of peer-reviewed studies, expert opinions, expert commentary with a special surprise admission from the “4-eyed little wizard behind the curtain himself buried somewhere below.

Acute Coronary Syndrome

Nov 18, 2021 ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine: https://www.thecardiologyadvisor.com/home/topics/acs/acute-coronary-syndrome-acs-biomarkers-mrna-covid19-vaccine/

Nov 8, 2021 Mrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: a caution:  https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712

Acute myelitis 

July 31, 2021 Acute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325554/

Alopecia Areata 

Dec 15, 2021 Alopecia areata after SARS-CoV-2 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8673931/

Nov 6, 2021 Recurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy:  https://onlinelibrary.wiley.com/doi/10.1111/jocd.14581

Sept 24, 2021 Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? https://onlinelibrary.wiley.com/doi/full/10.1111/jocd.14459

Anaphylaxis including Cutaneous Adverse Effects (Skin reactions)

Nov 9, 2021 Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17806

Nov 9, 2021 A case of toxic epidermal necrolysis after vaccination with ChAdOx1 nCoV-19 (AZD1222):  https://onlinelibrary.wiley.com/doi/10.1111/ajd.13742

Oct 28, 2021 Anaphylaxis after Modern COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8558796/

Oct 26, 2021 Association of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8548941/

Oct 22, 2021 Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8531274/

Oct 17, 2021 Cutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19: a prospective cohort study in health care workers:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17761

Oct 7, 2021 CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8504472/

Oct 5, 2021 Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656951/

Oct 1, 2021 Immunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data:  https://pubmed.ncbi.nlm.nih.gov/34269740/

Sept 21, 2021 Skin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases:  https://pubmed.ncbi.nlm.nih.gov/34254291/

Sept 17, 2021 Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8449279/

Sept 11, 2021 Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccination in health care workers taking ACE inhibitors:  https://www.mdpi.com/2076-393X/9/9/1011

Sept 10,2021 Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study:  https://pubmed.ncbi.nlm.nih.gov/34517079/

Sept 4, 2021 COVID-19 mRNA vaccine causing CNS inflammation: a case series:  https://link.springer.com/article/10.1007/s00415-021-10780-7

Sept 1, 2021 Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience:  https://pubmed.ncbi.nlm.nih.gov/34474708/

Aug 31, 2021 Anaphylaxis reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis following vaccination with Pfizer BNT162b2:  https://www.mdpi.com/2076-393X/9/9/974

Aug 31, 2021 Allergic reactions after COVID-19 vaccination: putting the risk in perspective:  https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783633

Aug 26, 2021 Reports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021:  https://pubmed.ncbi.nlm.nih.gov/34414880/

Aug 18, 2021 A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372465/

Aug 4, 2021 Cumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335977/

July 31, 2021 Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8325373/

July 28, 2021 IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444836/

July 23, 2021 Relationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220987/

July 22, 2021 Clinical and histopathologic spectrum of delayed adverse skin reactions after COVID-19 vaccination: https://onlinelibrary.wiley.com/doi/10.1111/cup.14104

July 19, 2021 An academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288228/

July 19, 2021 Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288253/

June 18, 2021 The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. : https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8248554/

June 14, 2021 Elevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data:  https://academic.oup.com/jtm/article/28/7/taab090/6298507

July 8, 2021 Bullous drug eruption after the second dose of COVID-19 mRNA-1273 (Moderna) vaccine: Case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264280/

June 6, 2021  Biphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242856/

May 29, 2021 Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19:  https://onlinelibrary.wiley.com/doi/10.1002/jmv.27109

May 6, 2021 Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8101867/

April 28, 2021 Anaphylaxis Associated with COVID-19 mRNA Vaccines: Approach to Allergy Research:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080508/

April 27, 2021 Cutaneous adverse effects of available COVID-19 vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076732/

April 21, 2021 Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143141/

April 19, 2021 Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and OGAI. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8054127/

April 14, 2021 Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria:  https://academic.oup.com/milmed/advance-article/doi/10.1093/milmed/usab138/6225467

April 9, 2021 Polyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251011/

April 7, 2021 Skin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases:  https://pubmed.ncbi.nlm.nih.gov/33838206/

April 6, 2021 Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies:  https://europepmc.org/article/PMC/PMC8023205

April 2, 2021 Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine: a case report and mechanism of action:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8021358/

April 1, 2021 Allergic reactions to COVID-19 vaccines: statement of the Belgian Society of Allergy and Clinical Immunology (BelSACI):  https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447

March 22, 2021 Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17237

March 8, 2021 Acute allergic reactions to COVID-19 mRNA vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941251/

March 3, 2021 Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013891/

Feb 28, 2021 Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021:  https://onlinelibrary.wiley.com/doi/10.1111/ajt.16517

Feb 28, 2021 Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020:  https://onlinelibrary.wiley.com/doi/10.1111/ajt.16516

Feb 24, 2021 Severe Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA: Position Statement of the German Allergy Societies: German Medical Association of Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA): LOTS OF CONFLICTS ON INTEREST: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7903024/

Feb 16, 2021 COVID-19 vaccines increase the risk of anaphylaxis: (Norwegian): https://tidsskriftet.no/2021/02/debatt/covid-19-vaksiner-gir-okt-risiko-anafylaksi https://pubmed.ncbi.nlm.nih.gov/33685103/  (no abstract available)

Feb 12, 2021 Reports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021:  https://jamanetwork.com/journals/jama/fullarticle/2776557

FEB 5, 2021 Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862013/

Feb 1, 2021 COVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization:.  https://www.worldallergyorganizationjournal.org/article/S1939-4551(21)00011-9/fulltext

Jan 29, 2021 Allergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842812/

Jan 21, 2021 Allergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine:  https://jamanetwork.com/journals/jama/fullarticle/2775646

Jan 15, 2021 Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808711/

Jan 5, 2021 Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences (6 OF THE 7 AUTHORS ARE ALSO LISTED IN THE FEB 24TH STUDY): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787363/

Jan 1, 2021 Pfizer Vaccine Raises Allergy Concerns:  https://ui.adsabs.harvard.edu/abs/2021Sci...371...10D/abstract

Dec 15, 2020 Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol:  https://onlinelibrary.wiley.com/doi/10.1111/all.14711

Antibody Dependent Enhancement (ADE)

Jan19, 2022 - Defective immunity and COVID-19 antibody dependent enhancement in Alberta, Canada: https://drjessesantiano.com/defective-immunity-and-covid-19-antibody-dependent-enhancement-in-alberta-canada/

Jan 6, 2022 57 Top Scientists And Doctors Release Shocking Study On COVID Vaccines And Demand Immediate Stop To All Vaccinations: https://fort-russ.com/2022/01/57-top-scientists-and-doctors-release-shocking-study-on-covid-vaccines-and-demand-immediate-stop-to-all-vaccinations/

Oct 10, 2021 A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8512237/

Sept 14, 2021 Antibody dependent enhancement: Unavoidable problems in vaccine development: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8438590/

June 3, 2021 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8175044/

Feb 24, 2021 Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7943455/

THEY WARNED US LONG BEFORE THE RELEASE DURING THE TRIALS

Sept 9, 2020 Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies: https://www.nature.com/articles/s41564-020-00789-5

Aug 12, 2020 COVID 19 Vaccines: Should we fear ADE?: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7454712/

June 5, 2020 Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures: https://www.nature.com/articles/s41587-020-0577-1

Fauci’s Admittance on ADE from March 26, 2020 - (notice the problems in his response) https://www.c-span.org/video/?c4864114/user-clip-fauci-speaks-vaccine-induced-disease-enhancement

Aphasia (Brain Disorders)

June 24, 2021 Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. : https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005

Appendicitis

Nov 3, 2021 Appendicitis as a possible safety signal for the COVID-19 vaccines: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8565092/

Aug 18, 2021 Appendicitis as a presentation of COVID-19: A case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8372448/

June 11, 2021 A Case of COVID-19 Mimicking Acute Appendicitis in Multi-System Inflammatory Syndrome: https://www.cureus.com/articles/54331-a-case-of-covid-19-mimicking-acute-appendicitis-in-multi-system-inflammatory-syndrome

Arthritis/Polyarthralgia/Myalgia/Still’s Disease(Syndrome)

Nov 29, 2021 Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. : https://ard.bmj.com/content/early/2021/11/28/annrheumdis-2021-221607.long

Nov 19, 2021 An outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8602986/

Oct 15, 2021  Arthritis following COVID-19 vaccination: report of two cases: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8516724/

Sept 7, 2021 Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors: https://onlinelibrary.wiley.com/doi/10.1002/art.41977

Aug 23, 2021 Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8405407/

May 25, 2021 Reactive arthritis after COVID-19 vaccination:  https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1920274

March 30, 2021  Flare of rheumatoid arthritis after COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8009616/

Asthma

Oct 19, 2021 Acute asthma exacerbation after SARS-CoV-2 vaccine (Sinovac®): a case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8562397/

Sept 20, 2021 COVID vaccination and asthma exacerbation: might there be a link? : https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8450144/

Auto-Immune Disorders (excluding Guillain–Barré syndrome)

Oct 6, 2021 Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient:  https://www.mdpi.com/2076-393X/9/10/1140

Oct 5, 2021 Immune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed:  https://www.sciencedirect.com/science/article/pii/S0168827821020936

Sept 22, 2021 Severe autoimmune hemolytic anemia after receipt of SARS-CoV-2 mRNA vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/trf.16672

Sept 7, 2021 Two cases of Graves’ disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants:  https://www.liebertpub.com/doi/10.1089/thy.2021.0142?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed

Aug 29, 2021 Hepatitis C virus reactivation after COVID-19 vaccination: a case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8412816/

Aug 10, 2021 Severe relapse of multiple sclerosis after COVID-19 vaccination: a case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8382847/

July 28, 2021 Autoimmune hepatitis triggered by vaccination against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316013/

July 22, 2021 Induction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/ced.14858

July 17, 2021 ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine:  https://www.sciencedirect.com/science/article/pii/S0272638621007423

July 15, 2021 Acute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279947/

July 13, 2021 Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination:  https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic

July 3, 2021 Autoimmune hepatitis after COVID vaccine:  https://www.sciencedirect.com/science/article/abs/pii/S0896841121000962?via%3Dihub

June 22, 2021 Autoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8219312/

May 31, 2021 ANCA glomerulonephritis following Modern COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8166044/

April 29, 2021 Immune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146571/

April 20, 2021 Autoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim?:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056822/

Bell’s Palsy/Facial Nerve Palsies

Nov 4, 2021 Left Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8566211/

Oct 28, 2021 Adverse event reporting and Bell's palsy risk after COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8550908/

Oct 28, 2021 Adverse event reporting and Bell's palsy risk after COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8550921/

Sept 26, 2021 Bell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8462203/

Sept 4, 2021 Facial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database:  https://www.sciencedirect.com/science/article/pii/S1201971221007049

Sept 1, 2021 Adverse event reporting and risk of Bell’s palsy after COVID-19 vaccination:  https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext

Aug 31, 2021 Bilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8425028/

August 16, 2021 Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study https://pubmed.ncbi.nlm.nih.gov/34411532/

Aug 16, 2021 The association between COVID-19 vaccination and Bell’s palsy:  https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00467-9/fulltext

Aug 4, 2021 Transient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine:  https://pubmed.ncbi.nlm.nih.gov/34369471/  (no abstract) https://journals.lww.com/jneuro-ophthalmology/Citation/9000/Transient_Oculomotor_Palsy_Following_the.98655.aspx

Aug 1, 2021 COVID-19 vaccination association and facial nerve palsy: A case-control study:  https://pubmed.ncbi.nlm.nih.gov/34165512/

July 29,2021 Bell’s palsy after COVID-19 vaccination with high antibody response in CSF:  https://link.springer.com/article/10.1007%2Fs10072-021-05496-5

July 22, 2021 Bell’s palsy after COVID-19 vaccination: case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295024/

July 19 - Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291314/

July, 17, 2021 A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine:.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8285283/

June 26, 2021 Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312995/

June 24, 2021 Association of COVID-19 Vaccination and Facial Nerve Palsy A Case-Control Study: https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2781367

June 7, 2021 Bell’s palsy and SARS-CoV-2 vaccines: an unfolding story:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184125/

May 25, 2021 Bell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/

May 24, 2021 Acute abducens nerve palsy after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142812/

May 20, 2021 Bell’s palsy after Ad26.COV2.S COVID-19 vaccination:  https://academic.oup.com/qjmed/article/114/9/657/6278926

May 11, 2021 Acute facial paralysis as a possible complication of SARS-CoV-2 vaccination:  https://pubmed.ncbi.nlm.nih.gov/33975372/ or https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1501-0470.pdf

April 2, 2021 Type I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8016545/

March 23, 2021 Peripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19):  https://ima-files.s3.amazonaws.com/268773_455e40fd-d140-410f-b1e3-e640b3ee158d.pdf or https://pubmed.ncbi.nlm.nih.gov/33734623/ (no abstract available)

Feb 24, 2021 Bell's palsy and SARS-CoV-2 vaccines: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7906673/

Feb 19, 2021 Reported orofacial adverse effects from COVID-19 vaccines: the known and the unknown:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013400/

Feb 10,2021 Bell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874945/

Feb 3, 2021 Bell’s palsy following COVID-19 vaccination https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897359/

Blood Clots/DVT/PE/Other Bleeding Disorders

Nov 27, 2021 Unusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19):  https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0882/_article

Nov 17, 2021 COVID-19 vaccine in patients with hypercoagulability disorders: a clinical perspective:  https://pubmed.ncbi.nlm.nih.gov/34786893/

Nov 15, 2021 Isolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8604520/

Oct 14, 2021 Deep venous thrombosis after vaccination with Ad26.COV2.S in adult males:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8516572/

Oct 9, 2021 An unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8576696/

Oct 8, 2021 BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531069/

Oct 6, 2021 Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: https://www.mdpi.com/1422-0067/22/19/10791

Aug 2, 2021 Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327605/

July 14, 2021 Pulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine:  https://casereports.bmj.com/content/14/7/e243975.long

June 23, 2021 Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220408/

April 29, 2021 Deep venous thrombosis more than two weeks after COVID-19 vaccination:  https://tidsskriftet.no/en/2021/04/kort-kasuistikk/deep-vein-thrombosis-more-two-weeks-after-vaccination-against-covid-19

March 9, 2021 Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940863/

“Breakthrough Cases” ie. Those who have been jabbed. LOL.. Yeah, I find it funny.

Dec 14, 2021 “SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact”
https://www.nature.com/articles/s41577-021-00662-4

June 14, 2021 - “Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals” https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8363499/

Cancer (non-lymph)

April 2024 - “Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan”
https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-#!/

April 2022 - “Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients”
https://www.mcpiqojournal.org/article/S2542-4548(21)00173-9/pdf

Feb 5, 2022 “Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line”
https://www.mdpi.com/1467-3045/44/3/73

Dec 7, 2021 - Humoral Responses after SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients: https://www.mcpiqojournal.org/article/S2542-4548(21)00173-9/pdf

Oct 6, 2021 Squamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech):  https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.14179

Aug 16, 2021 Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. 
https://onlinelibrary.wiley.com/doi/10.1002/pbc.29295

June 23, 2021 The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8220943/

Cardiomyopathy/ Encephalopathy 

Nov 3, 2021 Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564792/

Sept 6, 2021 Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report:  https://www.sciencedirect.com/science/article/pii/S2049080121007536

July 3, 2021 Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8254392/

Central Nervous System (CNS) demyelination 

Nov 9, 2021 A systematic review of cases of CNS demyelination following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8577051/

Oct 29, 2021  Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 mRNA vaccine; a case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8567291/

Sept 4, 2021 COVID-19 mRNA vaccination leading to CNS inflammation: a case series:https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8417681/

Cerebral Venous Thrombosis (CVT), AVT, VT. etc. 

Nov 15, 2022 Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: A case report https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.6505

Dec 24, 2021 Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI:  https://svn.bmj.com/content/6/4/668

Nov 23, 2021 Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: systematic review and meta-analysis:  https://n.neurology.org/content/97/21/e2136.long

Nov 22,2021 Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination and thrombotic thrombocytopenia syndrome:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8645635/

Nov 18, 2021 Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600336/

Nov 16, 2021 Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593397/

Nov 15, 2021 Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: report of three cases:  https://jnis.bmj.com/content/early/2021/11/15/neurintsurg-2021-018238.long

Nov 1, 2021 Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination:  https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785610

Oct 27, 2021 Cerebral venous sinus thrombosis following vaccination with ChAdOx1: the first case of definite thrombosis with thrombocytopenia syndrome in India:  https://casereports.bmj.com/content/14/10/e246455.long

Oct 11, 2021 CAd26.COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count:  https://www.mp.pl/paim/issue/article/16114/

Oct 5, 2021 Cerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more:  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-1736168

Oct 5, 2021 Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491181/

Oct 14, 2021 - Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination: https://www.cureus.com/articles/73542-cerebral-venous-sinus-thrombosis-after-bnt162b2-mrna-covid-19-vaccination

Sept 29, 2021 Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19: https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340

Sept 28, 2021 Characteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:  https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622

Sept 25, 2021 Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience:  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext

Sept 24, 2021 Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498326/

Sept 17, 2021 Cerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8490890/

Sept 14, 2021 Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8652852/

Sept 3, 2021 Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422566/

Aug 28, 2021 Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26336

Aug 23, 2021 Cerebral venous thrombosis associated with COVID-19 vaccine in Germany:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427115/

Aug 10, 2021 Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8352747/

Aug 7, 2021 [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination]:  https://pubmed.ncbi.nlm.nih.gov/34373413/

Aug 6, 2021 Cerebral venous sinus thrombosis after vaccination: the UK experience:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8346246/

Aug 4, 2021 Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444640/

Aug 1, 2021 Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia:  https://pubmed.ncbi.nlm.nih.gov/34333995/

July 30, 2021 Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with a high mortality rate: a case series:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8363077/

July 29, 2021 Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management:  https://pubmed.ncbi.nlm.nih.gov/34327553/

July 29, 2021 Cerebral venous sinus thrombosis after COVID-19 vaccination: neurologic and radiologic management:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320717/

July 21, 2021 Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8294245/

July 19, 2021 Cerebral venous thrombosis associated with the covid-19 vaccine in Germany:  https://onlinelibrary.wiley.com/doi/10.1002/ana.26172

July 18, 2021 Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event:  https://pubmed.ncbi.nlm.nih.gov/34133027/

July 10, 2021 Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344576/

July 8, 2021 A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265178/

July 1, 2021 Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051185/

June 24, 2021 Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation: https://www.sciencedirect.com/science/article/pii/S1871402121002046

June 22, 2021 US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:  https://pubmed.ncbi.nlm.nih.gov/33929487/

June 17, 2021 Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST):  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220435/

July 15, 2021 Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8561270/

June 12, 2021 59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212841/

June 8, 2021 Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186447/

June 8, 2021 Cerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186353/

May 25, 2021 Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine: https://www.strokejournal.org/article/S1052-3057(21)00309-8/fulltext

May 25, 2021Cerebral venous thrombosis induced by SARS-CoV-2 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8148433/

May 25, 2021 Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8148614/

May 24, 2021 Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141689/

May 10, 2021 The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108377/

May 10, 2021 Cerebral venous thrombosis following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108371/

May 6, 2021 Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination:  https://www.sciencedirect.com/science/article/pii/S0213485321000839

May 5, 2021 Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://www.bmj.com/content/373/bmj.n1114.long

May 2, 2021 Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346241/

April 20, 2021 Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8056834/

April 15,2021 Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):  https://www.bloodtransfusion.it/articolo.aspx?idart=003388&idriv=000162&idart=003388&idriv=000162

April 12, 2021 Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039796/

April 8, 2021 A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration:  https://www.mdpi.com/2075-4426/11/4/285

April 8, 2021 Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8028600/

Cutaneous/Keratolysis/Dermatosis/Bullous/Sweet’s Syndrome/etc (Skin Related)

Jan 17, 2022 Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.16309

Dec 1, 2021 Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine:  https://journals.lww.com/corneajrnl/Abstract/2021/12000/Bilateral_Immune_Mediated_Keratolysis_After.23.aspx

Nov 25, 2021 A case of generalized Sweet’s syndrome with vasculitis triggered by recent vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8612751/

Oct 7, 2021 Hematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination:  https://casereports.bmj.com/content/14/10/e245440.long

Oct 4, 2021 Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report:  https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4883

Sept 29, 2021 Sweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman:  https://onlinelibrary.wiley.com/doi/10.1111/dth.15146

Sept 12, 2021 Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria on cyclosporine treatment – A report of 3 cases:  https://onlinelibrary.wiley.com/doi/10.1111/jocd.14437

Sept 7, 2021 Case report: Pityriasis rosea-like rash after vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8452904/

Aug 25, 2021 Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8470727/

Aug 23, 2021 Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases:  https://onlinelibrary.wiley.com/doi/10.1111/dth.15110

Aug 7, 2021 Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17578

Aug 4, 2021 Onset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases:  https://onlinelibrary.wiley.com/doi/10.1111/dth.15085

Aug 3, 2021 Petechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8413049/

July 21, 2021 Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report: https://www.sciencedirect.com/science/article/pii/S1876034121001878

July 8, 2021 Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature:  https://onlinelibrary.wiley.com/doi/10.1111/ced.14835

July 3, 2021 Sweet syndrome induced by SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8441847/

June 18, 2021 Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine: https://onlinelibrary.wiley.com/doi/full/10.1111/all.14981

June 6, 2021 Dermatologic manifestations and complications of COVID-19: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7274995/

May 26, 2021 Coronavirus 19 presenting with atypical Sweet's syndrome: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16662

May 24, 2021 Petechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results:  https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794.long

DEATH

June 21, 2024 A Systematic REVIEW of Autopsy findings in deaths after covid-19 vaccination
https://www.sciencedirect.com/science/article/pii/S0379073824001968

Jan 14, 2024 Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis
https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14680

Apr 15, 2023 A Case Report of Creutzfeldt-Jakob Disease after mRNA
COVID-19 Vaccine
https://www.anncaserep.com/open-access/a-case-report-of-creutzfeldt-jakob-disease-after-mrna-covid-19-vaccine-9619.pdf

Dec 5, 2022 Fatal Post COVID mRNA-Vaccine Associated Cerebral Ischemia
https://pmc.ncbi.nlm.nih.gov/articles/PMC10091442/

Nov 27, 2022 Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
https://link.springer.com/article/10.1007/s00392-022-02129-5

Nov 8, 2022 Clinically suspected lethal viral myocarditis combined with encephalitis: a COVID-19 vaccine complication
https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14229

Sept 9, 2022 Do Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Change Creutzfeldt-Jakob Disease Prognosis?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469682/

Feb 22, 2022 Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose https://pubmed.ncbi.nim.nih.gov/35157759/

Jan 11, 2022 A fatal case of COVID-19 breakthrough infection due to the delta variant
https://onlinelibrary.wiley.com/doi/10.1002/ccr3.5232

Jan 19, 2022 POST COVID-19 VACCINE DEATHS - SINGAPORE’S EARLY EXPERIENCE:
https://www.sciencedirect.com/science/article/pii/S0379073822000299

Dec 15, 2021 Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review: https://www.mdpi.com/2077-0383/10/24/5876

Nov 27, 2021 Fatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544977/

Nov 15, 2021 Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries:
https://www.researchgate.net/publication/356248984_Worldwide_Bayesian_Causal_Impact_Analysis_of_Vaccine_Administration_on_Deaths_and_Cases_Associated_with_COVID-19_A_BigData_Analysis_of_145_Countries

Nov 6, 2021 An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review: 
https://www.mdpi.com/1422-0067/22/21/12024

Oct 11, 2021 Brain death in a vaccinated patient with COVID-19 infection:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8502685/

Oct 9, 2021 Lethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 26.COV2.S: first documented case outside the U.S.: 
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8501343/

Sept 30, 2021 Post-mortem investigation of deaths after vaccination with COVID-19 vaccines: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8482743/

Aug 18, 2021 Deaths associated with recently launched SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8372443/

Aug 12, 2021 Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins: a rationale for monitoring immunoglobulin G levels:  https://haematologica.org/article/view/haematol.2021.279509

Aug 11, 2021 COVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8359902/

Aug 2, 2021 Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352786/

Aug 1, 2021 Post-mortem findings in vaccine-induced thrombotic thrombocytopenia:  https://haematologica.org/article/view/haematol.2021.279075

July 14 ,2021 Over 5,200 post deaths reported following COVID-19 vaccination in Europe: https://www.precisionvaccinations.com/european-agency-confirms-covid-19-vaccine-fatalities

July 10, 2021 Myocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8524235/

June 23, 2021 Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination:  https://pubmed.ncbi.nlm.nih.gov/34171649/

May 26, 2021 COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://www.mdpi.com/2075-4418/11/6/955

May 19, 2021 Nursing home deaths after COVID-19 vaccination: https://tidsskriftet.no/en/2021/05/originalartikkel/nursing-home-deaths-after-covid-19-vaccination

May 13, 2021 Fatal cerebral venous sinus thrombosis after covid-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8117129/

April 29, 2021 Fatal cerebral hemorrhage after COVID-19 vaccine:  https://tidsskriftet.no/en/2021/04/kort-kasuistikk/fatal-cerebral-haemorrhage-after-covid-19-vaccine

April 17, 2021 Deaths associated with the recently launched SARS-CoV-2 vaccination (Comirnaty®):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8052499/

April 16, 2021 First case of postmortem study in a patient vaccinated against SARS-CoV-2: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8051011/

Jan 15, 2021 Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination: https://www.bmj.com/content/372/bmj.n149.long

Encephalitis /Myelitis/Encephalomyelitis/Meningoencephalitis/ Meningitis/Encepholapthy

Nov 30, 2021 Autoimmune encephalitis after ChAdOx1-S SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8630512/

Nov 4, 2021 Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8567127/

Sept 6, 2021 Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8420261/

Aug 13, 2021 Post-vaccinal encephalitis after ChAdOx1 nCov-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8426979/

July 21, 2021 Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8294707/

May 30, 2021 COVID-19-associated acute disseminated encephalomyelitis (ADEM): https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7260459/

May 20, 2021 Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8136261/

May 20, 2021 Acute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab:  https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1928463

Gastroparesis (delayed gastric emptying)

Nov 1, 2021 Gastroparesis after Pfizer-BioNTech COVID-19 vaccination:  https://journals.lww.com/ajg/Citation/2021/11000/Gastroparesis_After_Pfizer_BioNTech_COVID_19.27.aspx

Guillain Barre Syndrome

Dec 27, 2021 Guillain-Barré syndrome associated with COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8632191/

Dec 1, 2021 Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine:  https://pubmed.ncbi.nlm.nih.gov/34808658/ OR https://journals.lww.com/jcnmd/Citation/2021/12000/Clinical_Variant_of_Guillain_Barre_Syndrome_With.11.aspx

Nov 22, 2021 A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8690109/

Nov 22, 2021 Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8608454/

Nov 18, 2021 Guillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601771/

Nov 12, 2021 Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8586608/

Nov 11, 2021 Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report: https://actamedica.lfhk.cuni.cz/media/pdf/am_2021064030183.pdf

Oct 26, 2021 COVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy:  https://onlinelibrary.wiley.com/doi/10.1002/ana.26258

Oct 14, 2021 Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522664/

Oct 7, 2021 Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021:  https://jamanetwork.com/journals/jama/fullarticle/2785009

Oct 7, 2021 Guillain-Barre syndrome after COVID-19 vaccination in an adolescent:  https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext

Sept 28, 2021 Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8478139/

Sept 26, 2021 Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8546902/

Sept 21, 2021 A rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8529941/

Sept 20, 2021 A case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8462911/

Sept 17, 2021 AstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447540/

Sept 15, 2021 Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines:  https://onlinelibrary.wiley.com/doi/10.1002/ana.26218

Sept 14, 2021 A rare case of Guillain-Barré syndrome after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8523377/

Sept 1, 2021 Rate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine:  https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708

Aug 30, 2021 SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405530/

Aug 30,2021 Guillain-Barre syndrome after vaccination with mRNA-1273 against COVID-19:  https://pubmed.ncbi.nlm.nih.gov/34477091/ OR https://ugeskriftet.dk/videnskab/guillian-barres-syndrom-efter-mrna-1273-covid-19-vaccine

Aug 30, 2021 COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8405530/

Aug 28, 2021 SARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8397486/

Aug 13, 2021 Guillain-Barré syndrome after AstraZeneca COVID-19 vaccination: causal or casual association: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360997/ 

Aug 13, 2021 A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395825/

Aug 8, 2021 Sensory Guillain-Barré syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349403/

Aug 7, 2021 Guillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19: a case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346349/

Aug 4, 2021 Guillain-Barre syndrome after BNT162b2 COVID-19 vaccine:  https://link.springer.com/article/10.1007%2Fs10072-021-05523-5

July 30, 2021 A variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN:  https://elitmed.hu/en/publications/clinical-neuroscience/a-variant-of-guillain-barre-syndrome-after-sars-cov-2-vaccination-amsan

July 25, 2021 Facial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8381448/

July 17, 2021 A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34272622/

July 15, 2021 Guillain-Barré syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series:  https://onlinelibrary.wiley.com/doi/10.1111/ncn3.12537

July 14, 2021 Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine:  https://jnnp.bmj.com/content/early/2021/07/13/jnnp-2021-327027

June 30, 2021 Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report:  https://www.sciencedirect.com/science/article/pii/S0035378721005853?via%3Dihub

June 10, 2021 Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination: https://onlinelibrary.wiley.com/doi/10.1002/ana.26143

June 10, 2021 Variant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination:  https://onlinelibrary.wiley.com/doi/10.1002/ana.26144

June 5, 2021 COVID-19, Guillain-Barré and vaccineA dangerous mix:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8179060/

April 30, 2021 Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8086372/

April 22, 2021 Guillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070856/

Feb 18, 2021 Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7978140/

Jan 13, 2021 GM1 ganglioside antibody and COVID-19-related Guillain Barre syndrome: case report, systemic review, and implications for vaccine development:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805391/

Hailey Hailey Disease

Aug 25, 2021 Hailey-Hailey disease exacerbation after SARS-CoV-2 vaccination:  https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3907

Headache

Sept 17, 2021 Delayed headache after COVID-19 vaccination: a warning sign for vaccine-induced cerebral venous thrombosis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8446734/

Sept 15, 2021 Vaccine-induced thrombocytopenia with severe headache:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522796/

Sept 5, 2021 Vaccine-induced thrombocytopenia with severe headache: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522796/

July 27, 2021 Headache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8314854/

Hearing Loss

Nov 30, 2021 Sudden sensorineural hearing loss after covid-19 vaccine; A possible adverse reaction? https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8629793/

Oct 17, 2021 Sudden sensorineural hearing loss after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8520501/

Aug 25, 2021 Sudden Sensorineural Hearing Loss Following the Second Dose of COVID-19 Vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8462391/

July 9, 2021 - Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8443418/

Hematuria

April 28, 2021 A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8079938/

March 24, 2021 Gross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7987498/

Hemichorea-Hemiballismus Syndrome 

Acute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8661968/

Hemorrhage / Hemorrhagic Stroke Menstrual Bleeding/Vasculitis(any)

Jan 1, 2022 Cutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality: https://journals.lww.com/amjdermatopathology/Fulltext/2022/01000/Cutaneous_Lymphocytic_Vasculitis_After.19.aspx

Dec 24, 2021 Peduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8443534/

Dec 5, 2021 Retinal hemorrhage after SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8658415/ 

Nov 30, 2021 Reactivation of IgA vasculitis after vaccination with COVID-19:  https://casereports.bmj.com/content/14/11/e247188.long

Nov 24, 2021 Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2: https://ard.bmj.com/content/early/2021/11/23/annrheumdis-2021-221248.long

Nov 22, 2021  Repeated Cardioembolic Stroke after COVID-19 mRNA Vaccination: A Case Report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8606267/

Nov 16, 2021 Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8594320/

Nov 14, 2021 IgA vasculitis following COVID-19 vaccination in an adult:  https://onlinelibrary.wiley.com/doi/10.1111/cup.14168

Nov 11, 2021 Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8632021/

Nov 10, 2021 Leukocytoclastic vasculitis after exposure to COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8578015/

Nov 9, 2021 Recurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients:  https://onlinelibrary.wiley.com/doi/10.1111/nep.13993

Nov 1, 2021 Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman:  https://haematologica.org/article/view/haematol.2021.279407

Nov 1, 2021 Imaging in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster: https://journals.sagepub.com/doi/10.1177/1358863X211055507?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Oct 28, 2021 Lobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA-based SARS-CoV-2 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/

Oct 28, 2021 Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.16212

Oct 27, 2021 Possible case of COVID-19 mRNA vaccine-induced small-vessel vasculitis:  https://onlinelibrary.wiley.com/doi/10.1111/jocd.14568

Oct 24, 2021 Induction of cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8609955/

Oct 13, 2021 Ischemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination:  https://jnnp.bmj.com/content/92/11/1247.long

Oct 12, 2021 Characterizing menstrual bleeding changes occurring after SARS-CoV-2 vaccination: https://www.medrxiv.org/content/10.1101/2021.10.11.21264863v1

Oct 9, 2021 Cutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8501511/

Oct 2, 2021 Occurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8487223/

Sept 30, 2021 Possible triggers of thrombocytopenia and/or hemorrhage by BNT162b2 vaccine, Pfizer-BioNTech:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8514746/

Sept 30, 2021 Cutaneous vasculitis following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8483649/

Sept 30, 2021 Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and crescentic Pauci-Inmune glomerulonephritis after vaccination with Pfizer-BioNTech COVID-19 mRNA:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8514980/

Sept 27, 2021 Incidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series: https://www.eurekaselect.com/article/118179

Sept 23, 2021 Rare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8461674/

Sept 21, 2021 Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 corona virus vaccine nCoV-19 (recombinant):  https://onlinelibrary.wiley.com/doi/10.1111/dth.15141

Sept 17, 2021 Case of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019:  https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.16167

Sept 16, 2021 Cutaneous small vessel vasculitis after COVID-19 vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/jocd.14452

Sept 16, 2021 Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8452996/

Sept 16, 2021 First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8443965/

Sept 9, 2021 IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8427903/

Sept 8, 2021 Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?;  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8424403/

Sept 3, 2021 Reactivation of IgA vasculitis after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8260100/

Sept 1, 2021 Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8486363/

Aug 31, 2021 Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8406020/

Aug 30, 2021 Intracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19:  https://pubmed.ncbi.nlm.nih.gov/34477089/

Aug 17, 2021 A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8372491/

Aug 8, 2021 COVID-19 vaccine-induced urticarial vasculitis:  https://onlinelibrary.wiley.com/doi/10.1111/dth.15093

July 31, 2021 Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination:  https://www.mdpi.com/2076-393X/9/8/842

July 30, 2021 Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/dth.15076

July 26, 2021 Varicella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17550

July 26, 2021 Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17547

July 24, 2021 Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8310415/

July 17, 2021 Large hemorrhagic stroke after vaccination against ChAdOx1 nCoV-19: a case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444739/

July 17, 2021 ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8285210/

July 15, 2021 Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8561298/

July 14, 2021 Cutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad26.COV2.S:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8302840/

July 10, 2021 Nephrotic syndrome and vasculitis after SARS-CoV-2 vaccine: true association or circumstantial:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8344645/

July 9, 2021 New-onset leukocytoclastic vasculitis after COVID-19 vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/ijd.15777

July 5, 2021 Granulomatous vasculitis after AstraZeneca anti-SARS-CoV-2 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8256676/

July 1, 2021 A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report:  https://onlinelibrary.wiley.com/doi/10.1002/art.41910

June 24, 2021 Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269113/

June 11, 2021 Asymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophils:  https://onlinelibrary.wiley.com/doi/10.1111/ced.14797

May 11, 2021 Acral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8112292/

April 30, 2021 Outbreak of leukocytoclastic vasculitis after COVID-19 vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/ijd.15623

April 29, 2021 Coronavirus disease vaccine 2019 (COVID-19) in systemic lupus erythematosus and neutrophil anti-cytoplasmic antibody-associated vasculitis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8084413/

Henoch-Schönlein Purpura ( aka Immunoglobulin A vasculitis (IgAV)

Sept 25, 2021 Henoch-Schönlein purpura following the first dose of COVID-19 viral vector vaccine: case report:  https://www.mdpi.com/2076-393X/9/10/1078

Sept 8, 2021 A rare case of Henoch-Schönlein purpura after a case report of COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8425851/

June 30, 2021 Henoch-Schönlein purpura occurring after vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8241653/

Immune-mediated Diseases (IMD) including IMRD, IMID

Jan 17, 2022 - Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force: (Survey which was a joke, bias much?) https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8762982/

Jan 15, 2022 - COVID-19 vaccination uptake among individuals with immune-mediated inflammatory diseases in Ontario, Canada between December 2020 and October 2021: a population-based analysis: https://www.jrheum.org/content/early/2022/01/10/jrheum.211148

Aug 27, 2021  COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00247-2/fulltext

May 6, 2021 The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses: https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1

April 29, 2021 Immune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2:  https://www.mdpi.com/2076-393X/9/5/435

Kawasaki Disease 

Jan 16, 2022 Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization: https://pubmed.ncbi.nlm.nih.gov/35062787/

Feb 24, 2021 Post-COVID-19 Outbreak of Severe Kawasaki-like Multisystem Inflammatory Syndrome in Children: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7909350/

Kidney

Aug 3, 2021 Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8329426/

July 7, 2021 Minimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccine: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8260495/

July 6, 2021 Nephrotic syndrome after ChAdOx1 nCoV-19 vaccine against SARScoV-2:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8257404/

May 31, 2021 ANCA glomerulonephritis following Modern COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8166044/

May 15, 2021 Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8123374/

May 13, 2021 An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8116318/

April 8, 2021 Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8028833/

Kounis Syndrome

Jan 10, 2022  Kounis syndrome must be considered in the differential diagnosis of myocardial infarction following COVID-19 vaccination: https://academic.oup.com/qjmed/advance-article-abstract/doi/10.1093/qjmed/hcac001/6501457?redirectedFrom=fulltext

May 7, 2021 Kounis syndrome type 1 induced by inactivated SARS-COV-2 vaccine:  https://pubmed.ncbi.nlm.nih.gov/34148772/

Lipschütz Ulcers (You don’t want to know.. )

Aug 2, 2021 Lipschütz ulcers after AstraZeneca COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8327554/

Lung Disease

Sept 11, 2021 Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine:  https://thorax.bmj.com/content/77/1/9.long

Lymphadenopathy / Adenopathy/Other Lymph-related issues

Nov 25, 2021 Rapid progression of angioimmunoblastic T-cell lymphoma after BNT162b2 mRNA booster vaccination: case report:  https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/

Nov 17, 2021 Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8595349/

Nov 8, 2021 Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628154/

Nov, 2021 Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19): https://www.rcpjournals.org/content/clinmedicine/21/6/e677

Oct 26, 2021 COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: case series with literature review:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8547943/

Oct 26, 2021 COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628159/

Oct 16, 2021 COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8520081/

Oct 14, 2021 Rare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8516346/

Oct 11, 2021 Regional lymphadenopathy after COVID-19 vaccination: review of the literature and considerations for patient management in breast cancer care:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8502686/

Oct 2, 2021 Massive cervical lymphadenopathy following vaccination with COVID-19: https://journals.sagepub.com/doi/10.1177/01455613211048984?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Oct 2021 Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women:  https://www.ajronline.org/doi/10.2214/AJR.21.25651

Sept 16, 2021 Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476898/

Aug 25, 2021 COVID-19 post-vaccination lymphadenopathy: report of fine-needle aspiration biopsy cytologic findings:  https://onlinelibrary.wiley.com/doi/10.1002/dc.24863

Aug 18, 2021 Hemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19:  https://onlinelibrary.wiley.com/doi/10.1002/jmv.27279

Aug 16, 2021 Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4517

July 24, 2021 Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302478/

July 22, 2021 Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299355/

July 9, 2021 Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8268700/

June 26, 2021 Coronavirus disease vaccine 2019 mimics lymph node metastases in patients undergoing skin cancer follow-up: a single-center study:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8233908/

June 11, 2021 Lymphadenopathy associated with COVID-19 vaccination on FDG PET/CT: distinguishing features in adenovirus-vectored vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8411598/

June 10, 2021 COVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israel: analysis of 163 cases:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8189756/

June 6, 2021 Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8242856/

June 5, 2021 Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8178535/

May 16, 2021 A case of cervical lymphadenopathy following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8204135/

May 3, 2021 Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8575109/

May 1, 2021 Lymphadenopathy after COVID-19 vaccination: review of imaging findings:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8088218/

April 30,2021 COVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET:  https://www.sciencedirect.com/science/article/pii/S1930043321002612

April 21, 2021 COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic: a follow-up audit:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057932/

April 1, 2021 COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET / CT:  https://journals.lww.com/nuclearmed/Abstract/2021/04000/COVID_19_mRNA_Vaccination_Induced_Lymphadenopathy.18.aspx

March 27, 2021 Hypermetabolic lymphadenopathy after administration of BNT162b2 mRNA vaccine Covid-19: incidence assessed by [ 18 F] FDG PET-CT and relevance for study interpretation:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8003894/

March 26, 2021 Adverse events of COVID injection that may occur in children. Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7953532/

March 11, 2021 Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7953532/

March 4, 2021 Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7930521/

March 4, 2021 Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7931722/

Feb 24, 2021 Adenopathy after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909073/

Feb 24, 2021 Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7909072/

Feb 24, 2021 Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909070/

Feb 23, 2021 Lymphadenopathy associated with the COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994368/

Feb 15, 2021 Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883701/

Microscopic Polyangitis

July 12, 2021 Relapse of microscopic polyangiitis after COVID-19 vaccination: case report:  https://onlinelibrary.wiley.com/doi/10.1002/jmv.27192

Miller Fisher syndrome 

Nov 30, 2021 Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination:  https://casereports.bmj.com/content/14/11/e246701.long

Nov 24, 2021 Miller Fisher syndrome after Pfizer COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8611397/

Nov 18, 2021 Miller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8598937/

Multi-system Inflamatory Syndrome (MIS-A or MIS-C)

Dec 1, 2021 Post-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection:  https://pubmed.ncbi.nlm.nih.gov/34852213/

Nov 22, 2021 Multisystem Inflammatory syndrome following COVID-19 vaccination- ignored and underdiagnosed: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8690108/

Nov 18, 2021 Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?  https://www.mdpi.com/2076-393X/9/11/1353

Nov 5, 2021 Multisystem Inflammatory Syndrome in an Adult after COVID-19 Vaccination: a Case Report and Literature Review: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8608920/

Oct 7, 2021 Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine.  https://onlinelibrary.wiley.com/doi/10.1111/apa.16141

July 29, 2021 Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V): https://casereports.bmj.com/content/14/7/e243888

July 27, 2021 Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8237872/

May 19, 2021 Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779957

April 2, 2021 Adult multisystem inflammatory syndrome in apatient who recovered from COVID-19 postvaccination: https://casereports.bmj.com/content/bmjcr/14/4/e242060.full.pdf

Myocarditis/Pericarditis/Cardiomyopathy/Myopericarditis/Myocardial Infarction

July 20, 2023 - Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978

Aug 22, 2022, Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.122.059970?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org

Dec 25, 2021 Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) : https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0935/_article

Dec 22. 2021 mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8691954/

Dec 21, 2021 T2 mapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process:  https://europepmc.org/article/MED/34931681

Dec 17, 2021 Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?  https://www.jpeds.com/article/S0022-3476(21)01232-4/fulltext

Dec 16, 2021Myocarditis after vaccination against covid-19.  https://www.bmj.com/content/375/bmj.n3090.long

Dec 14. 2021 Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.  https://www.nature.com/articles/s41591-021-01630-0

Dec 9, 2021 Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8656213/

Dec 6, 2021 Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults:  https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Dec 5, 2021 Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval:  https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1

Dec 4, 2021 Chest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna:  https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8711-21/_article

Dec 4, 2021 Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination:  https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0840/_html/-char/en

Dec 3 Acute myocarditis associated with COVID-19 vaccination: report of a case:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/

Dec 3, 2021 Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2499

Dec 2, 2021 Hypersensitivity Myocarditis and COVID-19 Vaccines:  https://journals.viamedica.pl/kardiologia_polska/article/view/KP.a2021.0166/64903

Dec 1, 2021 Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children:  https://pubmed.ncbi.nlm.nih.gov/34374740/

Dec 1, 2021 Myocarditis associated with COVID-19 vaccination in three adolescent boys:  https://www.mp.pl/paim/issue/article/16160/

Nov 30, 2021 Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273:  https://casereports.bmj.com/content/14/11/e246059

Nov 28, 2021 Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination:  https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179

Nov 27, 2021Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series: https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8731-21/_article

Nov 26, 2021 Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:.  https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104

Nov 24, 2021 Perimyocarditis after vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8637777/

Nov 22, 2021 Acute myocarditis in a young adult two days after vaccination with Pfizer:  https://www.giornaledicardiologia.it/archivio/3689/articoli/36746/

Nov 22, 2021 Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in persons aged 75 years or older:  https://jamanetwork.com/journals/jama/fullarticle/2786667

Nov 8, 2021  68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8572651/

Nov 8, 2021 Acute pericarditis and cardiac tamponade after vaccination with Covid-19:  http://www.smj.org.sg/sites/default/files/CCF-2021-216-epub.pdf

Nov 6, 2021 Young male with myocarditis after mRNA-1273 coronavirus disease-2019 (COVID-19) mRNA vaccination:  https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0818/_html/-char/en

Nov 5, 2021 Myocarditis after COVID-19 vaccination: magnetic resonance imaging study:  https://academic.oup.com/ehjcimaging/advance- article/doi/10.1093/ehjci/jeab230/6421640

Nov 3, 2021 Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination:  https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408

Nov 2, 2021 Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8658061/

Nov 1, 2021 Myocarditis Following mRNA COVID-19 Vaccine:  https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx

Nov 1, 2021 Acute myocarditis after 2019 coronavirus disease vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8575404/

Nov 2021 COVID-19 Vaccination Associated with Myocarditis in Adolescents:  https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357/COVID-19-Vaccination-Associated-Myocarditis-in

Oct 30, 2021 Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/

Oct 29, 2021 Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8586196/

Oct 28, 2021 Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106

Oct 27, 2021 Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.  https://www.ajronline.org/doi/10.2214/AJR.21.26853

Oct 24, 2021 Acute myocardial infarction within 24 hours after COVID-19 vaccination: is Kounis syndrome the culprit:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8541841/

Oct 19, 2021 Acute myocarditis after COVID-19 vaccination: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8523482/

Oct 19, 2021 Myocarditis in the setting of a recent COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8548171/

Oct 18, 2021 Acute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/

Oct 15, 2021 Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8541143/

Oct 12, 2021 Case report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8545905/

Oct 12, 2021 Myocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series:  https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8731-21/_pdf/-char/en

Oct 11, 2021 The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.  https://smw.ch/article/doi/smw.2021.w30087

Oct 6, 2021 Myocarditis after Covid-19 Vaccination in a Large Health Care Organization: https://www.nejm.org/doi/full/10.1056/NEJMoa2110737

Oct 6, 2021 Myocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8531987/

Oct 5, 2021 A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8491922/

Oct 4, 2021 Acute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2784800

Oct 3, 2021 Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination:  https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab206/6380644

Oct 1, 2021 A report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8483988/

Oct 1. A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8506415/

Oct 2021 Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine:  https://journals.lww.com/pidj/Fulltext/2021/10000/Transient_Cardiac_Injury_in_Adolescents_Receiving.1.aspx

Sept 30, 2021 Myocardial infarction and azygos vein thrombosis after vaccination with ChAdOx1 nCoV-19 in a hemodialysis patient: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8489656/

Sept 30, 2021 A case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273: possible adverse effect:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8511584/

Sept 29,2021 Acute myocardial infarction and myocarditis after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/

Sept 27, 2021 STEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8469220/

Sept 24, 2021 Case report: symptomatic pericarditis post COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522432/

Sept 21, 2021 Severe myocarditis associated with COVID-19 vaccine: zebra or unicorn?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext

Sept 21, 2021 Myocarditis after COVID-19 mRNA vaccines:  https://academic.oup.com/qjmed/article/114/10/741/6373418

Sept 20, 2021 Myocarditis following COVID-19 vaccination.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8450283/

Sept 20, 2021 Acute myopericarditis after COVID-19 vaccination in adolescents:.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8476255/

Sept 16, 2021 COVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis:  https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09

Sept 11, 2021 A Late Presentation of COVID-19 Vaccine-Induced Myocarditis.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8504680/

Sept 9, 2021 Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8425992/

Sept 8, 2021 Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database:  https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1

Sept 8, 2021 Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database:  https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1

Sept 7, 2021 Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421108/

Sept 6, 2021 Biopsy-proven lymphocytic myocarditis after first COVID-19 mRNA vaccination in a 40-year-old man: case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419377/

Sept 4, 2021 Myocarditis following COVID-19 vaccination – A case series.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8416687/

Sept 1, 2021 COVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis:  https://www.mdpi.com/2036-7503/13/3/61

Sept 1, 2021 Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination:  https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478

Sept 1, 2021 Symptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination:  https://pediatrics.aappublications.org/content/148/3/e2021052478

Sept 1, 2021 Clinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA:  https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis

Aug 31, 2021 Reply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination”.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8499842/

Aug 31, 2021 Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8499841/

Aug 28, 2021  Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis? https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059

Aug 25, 2021 Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac tomography, and magnetic resonance imaging findings:  https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236

Aug 25, 2021 Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting: https://www.nejm.org/doi/full/10.1056/NEJMoa2110475

Aug 25, 2021 Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8478100/

August 18, 2021 Fulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372420/

Aug 18, 2021 Myocarditis following immunization with Covid-19 mRNA:  https://www.nejm.org/doi/full/10.1056/NEJMc2109975

Aug 18, 2021 Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8372420/

Aug 18, 2021 Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09

Aug 16, 2021 Be alert to the risk of adverse cardiovascular events after COVID-19 vaccination:  https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 

August 16, 2021 Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364889/

Aug 16, 2021 mRNA COVID vaccine and myocarditis in adolescents.  https://www.hkmj.org/system/files/hkmj215120.pdf

Aug 16, 2021 Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8369310/

Aug 13, 2021 COVID-19 Vaccination-Associated Myocarditis in Adolescents.  https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357/COVID-19-Vaccination-Associated-Myocarditis-in

Aug 10, 2021 (accepted) Myocarditis associated with COVID-19 vaccination in adolescents:  https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357

Aug 10, 2021 Myocarditis with COVID-19 mRNA vaccines:  https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135

Aug 10, 2021 Association of myocarditis with COVID-19 mRNA vaccine in children: (Original article removed from JAMA, however, “COVID-19 vaccine-associated myocarditis may have a benign short-term course in children; however, the long-term risks remain unknown”. https://clinicalnews.org/2021/08/10/association-of-myocarditis-with-mrna-covid-19-vaccine-in-children/

Aug 10, 2021 Association of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children:  https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052

Aug 9, 2021 Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369310/

Aug 9, 2021 Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8422910/

Aug 9, 2021 Myocarditis after SARS-CoV-2 mRNA vaccination, a case series:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8349733/

Aug 8, 2021 Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349733/

Aug 8, 2021 Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349442/

Aug 6, 2021 Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369314/

Aug 4, 2021 Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8422333/

Aug 4, 2021 Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334333/

Aug 4, 2021 Myocarditis and pericarditis after COVID-19 vaccination:  https://jamanetwork.com/journals/jama/fullarticle/2782900

Aug 3, 2021 Myocarditis Following COVID-19 Vaccination.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8369878/

Aug 2, 2021 Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326008/

Aug 2, 2021 Myocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination:  https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext

July 31, 2021 Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324414/

July 31, 2021 Occurrence of acute infarct-like myocarditis after COVID-19 vaccination: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325525/

July 30, 2021 Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8321962/

July 30, 2021 Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents: https://pubmed.ncbi.nlm.nih.gov/34339728/ OR https://www.sciencedirect.com/science/article/pii/S002234762100665X

July 29, 2021 Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8440228/

July 29, 2021 Myocarditis after BNT162b2 vaccination in a healthy male:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8238643/

July 28, 2021 Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine:  https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543

July 27, 2021 Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8328065/

July 24, 2021 Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: (nurse): https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8302854/

July 23, 2021 Unusual presentation of acute perimyocarditis after modern SARS-COV-2 mRNA-1237 vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381757/

July 21, 2021 Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441784/

July 20, 2021 Myocarditis with covid-19 mRNA vaccines:  https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135

July 20, 2021 Myocarditis associated with vaccination with COVID-19 mRNA:  https://pubs.rsna.org/doi/10.1148/radiol.2021211430

Jul 18, 2021 Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?  https://www.mdpi.com/2227-9067/8/7/607

July 16, 2021 Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8344506/

July 16, 2021 Pericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282480/ OR https://www.sciencedirect.com/science/article/pii/S1885585721002218

July 16, 2021 Myocarditis / pericarditis associated with COVID-19 vaccine: “This report builds on the expert discussion, summarizes scientific knowns and uncertainties, and suggests priority areas for consideration.” Later in the article “The benefits of vaccination, including prevention of COVID-19 infection and transmission as well as post-COVID complications such as long-COVID and MIS-C, outweigh the potential risk of vaccine-associated myocarditis and pericarditis but active monitoring and research are needed to understand and prevent vaccine-associated cardiac damage, now and in the future”. BULLSHIT. How can they make assumptions like this?  https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html

July 14, 2021 Acute myocarditis after SARS-CoV-2 mRNA-1273 mRNA vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8278869/

July 13, 2021 The new COVID-19 mRNA vaccine platform and myocarditis: clues to the possible underlying mechanism:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275472/

July 12, 2021 COVID-19 vaccine and myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272967/

July 12, 2021 Acute myocardial infarction within 24 hours after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272970/

July 10, 2021 Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8270057/

July 10, 2021 COVID-19 vaccine-induced myocarditis: Case report with literature review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270733/

July 10, 2021 Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8524235/

Jul 9, 2021 Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8312754/

July 3, 2021 Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the Vaccine Adverse Event Reporting System database:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255555/

July 3, 2021 Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8253718/

July 1, 2021 Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or causal relationship: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274899/

June 29, 2021 Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”:  https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601

June 29, 2021 Myocarditis following vaccination with BNT162b2 in a healthy male:  https://pubmed.ncbi.nlm.nih.gov/34229940/ 

https://www.sciencedirect.com/science/article/pii/S0735675721005362

June 29, 2021 Myocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines:  https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600

June 29, 2021 Patients with acute myocarditis after vaccination withCOVID-19 mRNA:  https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602

June 28, 2021 Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine:  https://www.cambridge.org/core/journals/cardiology-in-the-young/article/abs/selflimited-myocarditis-presenting-with-chest-pain-and-st-segment-elevation-in-adolescents-after-vaccination-with-the-bnt162b2-mrna-vaccine/22579D1974BCD41E9CECC545A1119F6D#

June 26, 2021 COVID-19 vaccines and myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233865/

June 22, 2021 Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/

June 17, 2021 Acute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases:  https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext

June 16, 2021 Myocarditis temporally associated with COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340723/

June 16, 2021 Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8245050/

June 16, 2021 Acute myocarditis following administration of BNT162b2 vaccine https://pubmed.ncbi.nlm.nih.gov/34189042/

June 16, 2021 In-depth evaluation of a case of presumed myocarditis after the second dose of  COVID-19 mRNA vaccine:  https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038

June 16, 2021 A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219373/

June 16, 2021 Acute myocarditis after administration of BNT162b2 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220234/

June 16, 2021 Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report.  https://onlinelibrary.wiley.com/doi/10.1111/acem.14322

June 14, 2021 COVID-19 mRNA vaccination and myocarditis:  https://pubmed.ncbi.nlm.nih.gov/34268277/

June 12, 2021 Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8196309/

June 10, 2021 Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines: https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines 

June 9, 2021 Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187737/

May 31, 2021 Acute myocarditis associated with anti-COVID-19 vaccination:  https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196

May 28, 2021 Myocarditis following COVID-19 mRNA vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8162819/

May 18, 2021 Myocarditis following COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8130498/

April 27, 2021 Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:  https://www.revespcardiol.org/en-acute-myocarditis-after-administration-bnt162b2-articulo-S188558572100133X

March 31, 2021 Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011690/

March 2, 2021 Premature myocardial infarction or side effect of COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8012173/

Jan 4, 2021 Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase:  https://www.mdpi.com/2076-393X/9/1/19

Myositis (muscles)

Sept 23, 2021 Inflammatory myositis after vaccination with ChAdOx1:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8460178/

July 3, 2021 COVID-19 and Myositis: What We Know So Far https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8254439/

Feb 27, 2021 COVID-19 vaccine-related myositis https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7989152/

Necrosis

Dec 1, 2021 Acute retinal necrosis due to varicella zoster virus reactivation after vaccination with BNT162b2 COVID-19 mRNA: https://www.tandfonline.com/doi/abs/10.1080/09273948.2021.2001540?journalCode=ioii20

Nov 28, 2021 Genital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17837

July 29, 2021 Cutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444634/

Nephrotic Syndrome 

Jan 4, 2022 A young adult with nephrotic syndrome following COVID-19 vaccination: https://europepmc.org/article/PMC/PMC8723818

July 28, 2021 New-onset nephrotic syndrome after Janssen COVID-19 vaccination: case report and literature review:  https://pubmed.ncbi.nlm.nih.gov/34342187/

July 10, 2021 Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8344645/

May 15, 2021 Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8123374/

May 6, 2021 COVID-19-associated nephritis: early warning for disease severity and complications?: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31041-2.pdf

April 8, 2021 Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8028833/

Neurological/Neuromuscular/Neurodegenerative Diseases/Neuromyelitis/CNS

Nov 19, 2021 Spectrum of neuroimaging findings in post-CoVID-19 vaccination: a case series and review of the literature:  https://www.mdpi.com/2035-8377/13/4/61

Nov 8, 2021 Neurological side effects of SARS-CoV-2 vaccines:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8653194/

Oct 31 2021 Spectrum of neurological complications after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8557950/

Oct 26, 2021 Cardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8547775/

Oct 25, 2021 Neurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8629105/

Oct 19, 2021 Neurological autoimmune diseases after SARS-CoV-2 vaccination: a case series:  https://onlinelibrary.wiley.com/doi/10.1111/ene.15147

Oct 13, 2021 In-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8511874/

Sept 14, 2021 Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8516014/

Sept 14, 2021 Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase:  https://www.mdpi.com/2076-393X/9/9/1022

Sept 6, 2021 Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence:  https://www.clinicalimaging.org/article/S0899-7071(21)00355-7/fulltext

Sept 4, 2021 COVID-19 mRNA vaccine causing CNS inflammation: a case series:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8417681/

Aug 23, 2021 Nerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402736/

July 28, 2021 Amyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8316086/

June 29, 2021 Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8241205/

June 1, 2021 Unique imaging findings of neurologic phantosmia after Pfizer-BioNtech COVID-19 vaccination: a case report:  https://journals.lww.com/topicsinmri/Fulltext/2021/06000/Unique_Imaging_Findings_of_Neurologic_Phantosmia.2.aspx

Pancreatic Issues

Nov 12, 2021 Pancreas allograft rejection after ChAdOx1 nCoV-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8586722/

Nov 2, 2021 -  Association between Acute Pancreatitis and COVID-19: Could Pancreatitis Be the Missing Piece of the Puzzle about Increased Mortality Rates? https://www.tandfonline.com/doi/full/10.1080/08941939.2020.1833263

June 1, 2021 Pancreatic Injury after COVID-19 Vaccine—A Case Report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8228266/

April 28, 2021 Acute Pancreatitis: A Possible Side Effect of COVID-19 Vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8163516/

Parsonage-Turner Syndrome 

Dec 22, 2021 Parsonage-Turner Syndrome After COVID-19 Vaccination: A Case Report: https://pubmed.ncbi.nlm.nih.gov/34936579/

Dec 13, 2021 Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667016/

Sept 24, 2021  Parsonage-Turner Syndrome After SARS-CoV-2 BNT162b2 Vaccine: A Case Report: https://pubmed.ncbi.nlm.nih.gov/34559695/

June 15, 2021 Parsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy” by Coll et al. Articular Spine 2021; 88: 10519:  https://pubmed.ncbi.nlm.nih.gov/34139321/

Pneumonia (any)

Nov 9, 2021 Interstitial pneumonitis after COVID-19 vaccination: A report of three cases: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8576592/

Oct 21, 2021 Acute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8604432/

Pregnancy Issues

Jan 24, 2024 Transplacental Transmission of the COVID-19 Vaccine mRNA: Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination:
https://www.ajog.org/article/S0002-9378(24)00063-2/pdf

Sept 28, 2022 COVID-19 Vaccines: The Impact on Pregnancy Outcomes
and Menstrual Function: https://www.jpands.org/vol28no1/thorp.pdf

Jan 13 2022 The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(21)00250-8/fulltext

Sept 8, 2021 Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy: https://jamanetwork.com/journals/jama/fullarticle/2784193

June 10, 2021 Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8189739/

April 21, 2021 Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8117969/

Prion Disease

Jan 18, 2021 COVID-19 RNA-based vaccines and the risk of prion disease:  https://dundasvalley.files.wordpress.com/2021/03/covid19-rna-based-vaccines-and-the-risk-of-prion-disease-1503.pdf

Retinopathy/Neuroretinopathy/Ocular

Sept 25, 2021 Central retinal vein occlusion after vaccination with SARS-CoV-2 mRNA: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8597478/

Sept 24, 2021 Ocular adverse events following COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8477588/

Sept 2, 2021 Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2783653?widget=personalizedcontent&previousarticle=2782394

July 21, 2021 Bilateral acute macular neuroretinopathy after SARS-CoV-2 vaccination:  https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2782394

June 12, 2021 Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine:.  https://www.sciencedirect.com/science/article/pii/S2451993621001456

Rhabdomyolysis

Aug 25, 2021 COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis:  https://link.springer.com/article/10.1007/s00415-021-10768-3

June 15, 2021 COVID-19 vaccine-induced rhabdomyolysis: case report with literature review:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205294/

Schamberg Disease

July 8, 2021 Generalized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17497

Seizures

Dec 1, 2021 - A Seizure After COVID-19 Vaccination in a Patient on Clozapine: https://journals.lww.com/psychopharmacology/Citation/2021/11000/A_Seizure_After_COVID_19_Vaccination_in_a_Patient.16.aspx

June 21, 2021 COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8216683/

June 7 2021 New-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182981/

May 8, 2021 Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence? https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8105133/

Splenic Infarction

Dec 7, 2021 Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19: https://casereports.bmj.com/content/14/12/e243846.long

Mar 23, 2021 COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7986315/

Systemic Capillary Leak Syndrome

Aug 6, 2021 Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8432311/

June 15, 2021 Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8252024/

Takotsubo Syndrome (stress cardiomyopathy)

Nov 3, 2021 Takotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysis:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564792/

Oct 8, 2021 Takotsubo (stress) cardiomyopathy after vaccination with ChAdOx1 nCoV-19:  https://casereports.bmj.com/content/14/10/e246580.long

Sept 15, 2021 Takotsubo syndrome after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440167/

July 15, 2021 Takotsubo cardiomyopathy after vaccination with mRNA COVID-19:  https://www.sciencedirect.com/science/article/pii/S1443950621011331

Thrombocytopenia 

Jan 1, 2022 ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107,720 doses of ChAdOx1 vaccination in Thailand:  https://journals.lww.com/bloodcoagulation/Abstract/2022/01000/ChAdOx1_nCoV_19_vaccine_associated.10.aspx

Nov 17, 2021 Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8595970/

Oct 30,2021 Immune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8556135/

Oct 29, 2021 Case report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8575766/

Oct 27, 2021 Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8565691/

Oct 23, 2021 A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8607313/

Oct 7, 2021 Severe immune thrombocytopenia following COVID-19 vaccination: report of four cases and review of the literature:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8494992/

Sept 30, 2021 Relapse of immune thrombocytopenia after COVID-19 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/ejh.13713

Sept 18, 2021 Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19:  https://onlinelibrary.wiley.com/doi/10.1002/rth2.12580

Sept 14, 2021 Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8500336/

Aug 26, 2021 Immune thrombocytopenia after vaccination during the COVID-19 pandemic: (download pdf) https://haematologica.org/article/view/haematol.2021.279442

Aug 22, 2021 Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination:  https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.14978

Aug 20, 2021 Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8415511/

Aug 19, 2021  Comment on: Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8441642/

Aug 4, 2021 Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8414938/

Aug 4, 2021 Immune thrombocytopenia associated with Pfizer-BioNTech’s COVID-19 BNT162b2 mRNA vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336989/

July 31, 2021 Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination:  https://onlinelibrary.wiley.com/doi/10.1002/pbc.29271

July 30, 2021 Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination:  https://casereports.bmj.com/content/14/7/e242678

July 27, 2021 Thrombocytopenia after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313538/

June 30, 2021 Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report: https://www.ncbi.nlm.nih.gov//pmc/articles/PMC8324423/

June 24, 2021 Exacerbation of immune thrombocytopenia after COVID-19 vaccination:  https://pubmed.ncbi.nlm.nih.gov/34075578/

June 23, 2021 Immune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: (download pdf to view Case Report) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=06&page=341

June 8, 2021 Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia:  https://www.thrombosisresearch.com/article/S0049-3848(21)00357-1/fulltext

June 2, 2021 Immune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2:  https://onlinelibrary.wiley.com/doi/10.1111/jdv.17444

May 31, 2021 Secondary immune thrombocytopenia putatively attributable to COVID-19 vaccination:  https://casereports.bmj.com/content/14/5/e242220.abstract

May 5, 2021 Newly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8176657/

May 1, 2021 Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/

April 30, 2021 Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS):  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086806/

April 28, 2021 An observational study to identify the prevalence of thrombocytopenia and anti-PF4 / polyanion antibodies in Norwegian health care workers after COVID-19 vaccination:  https://onlinelibrary.wiley.com/doi/10.1111/jth.15352

April 28, 2021 Prothrombotic immune thrombocytopenia after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084604/

April 20, 2021 Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine:.  https://onlinelibrary.wiley.com/doi/10.1111/jth.15347

April 9, 2021 Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”:  https://pubmed.ncbi.nlm.nih.gov/33918932/

April 6, 2021 Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040692/

March 25, 2021 Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/

March 9, 2021 Thrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/

March 1, 2021 Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19):  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265330/

Feb 19, 2021 Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.  https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132

Feb 12, 2021 Idiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine:  https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext

Feb 11, 2021 Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014773/

Thrombosis/Thromboembolism incl Venous Sinus Thrombosis (VST), Acute

Nov 29, 2021 COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8666479/

Nov 29, 2021 Major artery thrombosis and vaccination against ChAdOx1 nCov-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8627790/

Nov 15, 2021 Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database: https://www.mdpi.com/2076-393X/9/11/1326

Nov 10, 2021 Thrombotic events after COVID-19 vaccination in over 50 years of age: results of a population-based study in Italy:  https://www.mdpi.com/2076-393X/9/11/1307

Nov 10, 2021 Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern for underlying disease:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8586168/

Nov 8, 2021 New portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19:  https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext

Oct 25, 2021 Potential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8560237/

Oct 10,2021 Multiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx1 (AstraZeneca), which required emergency femoral and carotid surgical thrombectomy:  https://www.annalsofvascularsurgery.com/article/S0890-5096(21)00679-8/fulltext

Oct 12, 2021 Adenovirus-Vectored COVID-19 Vaccine–Induced Immune Thrombosis of Carotid Artery: https://n.neurology.org/content/97/15/716.long

Sept 30, 2021 Thrombosis formation after COVID-19 vaccination immunologic aspects: review article:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8489518/

Oct 6, 2021 Diffuse prothrombotic syndrome after administration of ChAdOx1 nCoV-19 vaccine: case report:  https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-021-03083-y

Sept 9, 2021 Autoimmunity roots of thrombotic events after vaccination with COVID-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8426137/

Sept 3, 2021 “Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413101/

Sept 2, 2021 Thrombosis of the palmar digital vein after Oxford‐AstraZeneca COVID‐19 vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652811/

Sept 1, 2021 Thrombosis in pre- and post-vaccination phase of COVID-19;  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503327/

Aug 28, 2021 Thrombosis after COVID-19 vaccination: possible link to ACE pathways:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397505/

Aug 20, 2021 Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376560/

Aug 18, 2021 Immune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia:  https://academic.oup.com/eurheartj/article/42/39/4064/6354117

Aug 14, 2021 A case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA:  https://www.mdpi.com/2076-393X/9/8/903

Jul 26, 2021 Thromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8330010/

July 14, 2021 Case report Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?:  https://casereports.bmj.com/content/14/7/e243799

July 2, 2021 Predicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275463/

June 16, 2021 Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206184/

June 15, 2021 Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204660/

June 8, 2021Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine:  https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/

May 28, 2021 Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159713/

May 19, 2021 Atypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca): data from the French network of regional pharmacovigilance centers:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165560/

May 3, 2021 Acute thrombosis of the coronary tree after vaccination against COVID-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092130/

Feb 1, 2021 Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines.  https://journals.lww.com/jcardiovascularmedicine/Fulltext/2022/02000/Concerning_the_unexpected_prothrombotic_state.1.aspx

Thrombotic Thrombocytopenia, VITT) or Thrombosis-Throbocytopenia

Jan 4, 2022  Post COVID-19 Vaccine Related Cerebral Venous Sinus Thrombosis and Thrombocytopenia: https://assets.cureus.com/uploads/case_report/pdf/81913/20220106-11592-i3k4v8.pdf

Dec 15, 2021 -Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689609/

Dec 15, 2021 Comments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia:  https://www.liebertpub.com/doi/10.1089/vim.2021.0118?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed

Dec 2, 2021 Information on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8483989/

Nov 27, 2021 A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8626153/

Nov 23, 2021 Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8649717/

Nov 17, 2021 Complicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A:  https://www.mdpi.com/2076-393X/9/11/1344

Nov 12, 2021 Case study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine:  https://www1.racgp.org.au/ajgp/coronavirus/thrombosis-following-astrazeneca-vaccine/

Nov 9, 2021 Case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8652623/

Nov 3, 2021 VITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOx1 nCoV-19:  https://www.nejm.org/doi/10.1056/NEJMc2111026?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Nov 1, 2021 Case report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8591100/

Oct 26, 2021 COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): systematic review and post hoc analysis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8552386/

Oct 26, 2021 Vaccine-associated thrombocytopenia and thrombosis: venous endotheliopathy leading to combined venous micro-macrothrombosis:  https://www.mdpi.com/1648-9144/57/11/1163

Oct 21, 2021 Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE):  https://pubmed.ncbi.nlm.nih.gov/34672380/

Oct 21, 2021 Neuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOx1 nCoV-19 vaccine: NO ABSTRACT PAYWALL FOR MAGONLINE: https://pubmed.ncbi.nlm.nih.gov/34726934/

Oct 20, 2021 Thrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad26.COV2.S vaccine (Janssen):  https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1674-0341

Oct 19, 2021 ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome: https://www.science.org/doi/10.1126/sciadv.abl8213

Oct 18, 2021 Vaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a new hypothesis on mechanisms and implications for future vaccine development:  https://onlinelibrary.wiley.com/doi/10.1111/imcb.12505

Oct 14, 2021 Thrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8524636/

Oct 13, 2021 Bilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8606181/

Oct 8, 2021 COVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation:  https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0041-1735453

Oct 6, 2021 Successful treatment of vaccine-induced immune immune thrombotic thrombocytopenia in a 26-year-old female patient:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8678222/

Oct 1, 2021 Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19: https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1579-9303

Sept 30,2021 Understanding the risk of thrombosis with thrombocytopenia syndrome following Ad26.COV2.S vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8482953/

Sept 27, 2021 Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT): https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8477249/

Sept 24, 2021 Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8498326/

Sept 21, 2021 Abdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8500008/

Sept 21, 2021 Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8500026/

Sept 20,2021 Concerns for adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8642058/

Sept 17, 2021 A rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital:  https://casereports.bmj.com/content/14/9/e244223.long

Sept 15, 2021 Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review:  https://pubmed.ncbi.nlm.nih.gov/34365148/

Sept 10, 2021 COVID-19 vaccine-induced thrombotic thrombocytopenia: a case series:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8432416/

Sept 8, 2021 COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8425075/

Sept 6, 2021 Australian and New Zealand approach to the diagnosis and treatment of vaccine-induced immune thrombosis and immune thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8661608/

Sept 2, 2021 Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × 1 nCov-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8634168/

Aug 28, 2021 Treatment of acute ischemic stroke associated with ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8397593/

Aug 27, 2021 Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. https://www.bmj.com/content/374/bmj.n1931.long

Aug 27, 2021 The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390120/

Aug 26, 2021 Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study:  https://pubmed.ncbi.nlm.nih.gov/34446426/

Aug 25, 2021 Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature:  https://www.europeanreview.org/article/26464

Aug 19, 2021 Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8634187/

Aug 17, 2021 Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8488810/

Aug 12, 2021 Venous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8632250/

Aug 11, 2021 Clinical features of vaccine-induced thrombocytopenia and immune thrombosis:  https://www.nejm.org/doi/10.1056/NEJMoa2109908?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Aug 10,2021 Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites:  https://onlinelibrary.wiley.com/doi/10.1111/jth.15493

Aug 3, 2021 Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330139/

Aug 2, 2021 Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329262/

Aug 2, 2021 Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8327605/

July 30,2021 Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363077/

July 18,2021 Coronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT):  (BOOK) https://www.ncbi.nlm.nih.gov/books/NBK570605/

July 15, 2021Thrombotic thrombocytopenic purpura: a new threat after COVID bnt162b2 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8280631/

July 14, 2021 Pulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: https://casereports.bmj.com/content/14/7/e243975

July 10, 2021 Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271354/

July 10, 2021  Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270740/

July 10, 2021 Primary adrenal insufficiency associated with thrombotic immune thrombocytopena induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):  https://pubmed.ncbi.nlm.nih.gov/34256983/ OR https://www.ejinme.com/article/S0953-6205(21)00236-3/fulltext

July 8, 2021 Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444929/

July 7, 2021 Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia:  https://www.nature.com/articles/s41586-021-03744-4

July 5, 2021 First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine:  https://onlinelibrary.wiley.com/doi/10.1111/jth.15418

July 3, 2021 Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8253724/

June 30, 2021 Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243058/

June 30, 2021 Thrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342878/

June 30,2021 Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8276919/

June 29,2021 Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?:  https://www.sciencedirect.com/science/article/pii/S0953620521002314

June 29, 2021 Thrombosis with thrombocytopenia after messenger RNA vaccine -1273:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251935/

June 24, 2021 Acute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy:  https://www.strokejournal.org/article/S1052-3057(21)00345-1/fulltext

June 22, 2021 Vaccine-induced immune thrombotic thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations:  https://onlinelibrary.wiley.com/doi/10.1111/bjh.17613

June 18, 2021 Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217988/

June 17, 2021 A case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219289/

June 15, 2021 Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204296/

June 9, 2021 First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282499/

June 9, 2021COVID‐19 vaccine‐associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239516/

June 9, 2021 Immunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8362588/

June 8, 2021 Acquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237075/

June 7, 2021 Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT):  https://onlinelibrary.wiley.com/doi/10.1111/bjh.17619

June 7, 2021 Vaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism:  https://onlinelibrary.wiley.com/doi/10.1002/ajh.26265

May 31, 2021 Thrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy:  https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258

May 28, 2021 Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia:  https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13629

May 27, 2021 Thrombotic thrombocytopenia after vaccination with COVID-19: in search of the underlying mechanism:  https://www.mdpi.com/2076-393X/9/6/559/htm

May 25, 2021 Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143907/

May 25, 2021 Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148431/

May 24, 2021 Limb ischemia and pulmonary artery thrombosis after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): a case of vaccine-induced immune thrombotic thrombocytopenia:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8248449/

May 22, 2021 Immediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8140563/

May 21, 2021 A case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosis:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8297676/

May 20, 2021 Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19):  https://haematologica.org/article/view/haematol.2021.279075

May 20, 2021 Procoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327736/

May 19, 2021 Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133385/

May 19, 2021 PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia:  https://www.nejm.org/doi/full/10.1056/NEJMc2106383

May 18, 2021 Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130591/

May 15, 2021 Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123522/

May 4, 2021 Thrombotic thrombocytopenic purpura after vaccination with Ad26.COV2-S:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8095021/

April 30, 2021 COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086259/

April 30, 2021 Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8086806/

April 30,2021 U.S. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8087975/

April 29, 2021 Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia:
https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.121.035564?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org

April 28, 2021 Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study:  https://www.bmj.com/content/373/bmj.n1114.long

Apr 28, 2021 Images of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8080133/

April 20, 2021 - Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:  https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X

April 16, 2021 Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:  https://www.nejm.org/doi/full/10.1056/nejme2106315

April 14, 2021 Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046413/

April 13, 2021 Vaccine-induced immune thrombotic immune thrombocytopenia (VITT): targeting pathologic mechanisms with Bruton’s tyrosine kinase inhibitors:  https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1481-3039

April 9, 2021 Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19:  https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article

March 29,2021 A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination:  https://www.semanticscholar.org/paper/A-Prothrombotic-Thrombocytopenic-Disorder-Following-Greinacher-Thiele/8497f2726d66b0bc95a06395f823362f18f49fc2

March 1, 2021A rare case of thrombosis and thrombocytopenia of the superior ophthalmic vein after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8265377/

Thyroiditis 

May 27, 2021 Three cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8194612/

Tolosa-Hunt Syndrome (severe and unilateral headaches with orbital pain, along with weakness and paralysis of certain eye muscles)

July 31, 2021 Tolosa-Hunt syndrome occurring after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8405240/

Transverse Myelitis (Acute, Cervical Vaccine Induced, etc)

Nov 25, 2021 Longitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8614237/

Oct 12, 2021 Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-021-02427-x

Oct 4, 2021 Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination: https://casereports.bmj.com/content/14/10/e245816

Sept 25, 2021 - Acute Transverse Myelitis after COVID-19 Vaccination https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540274/

Sept 21, 2021 Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8439525/

Sept 10, 2021 Acute transverse myelitis after COVID-19 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8470728/

Sept 5, 2021 Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8418691/

Aug 28, 2021 SARS-CoV-2 vaccination complicated by acute, disseminated encephalo-myelitis?: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8402996/

Aug 23, 2021 Post COVID-19 transverse myelitis; a case report with review of the literature: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8380545/

July 30, 2021 Acute transverse myelitis after inactivated COVID-19 vaccine https://elitmed.hu/en/publications/clinical-neuroscience/acute-transverse-myelitis-after-inactivated-covid-19-vaccine (you need an account) or https://pubmed.ncbi.nlm.nih.gov/34370410/

July 25, 2021 Transverse myelitis induced by SARS-CoV-2 vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384391/

July 24, 2021  A case of longitudinally extensive transverse myelitis following vaccination against Covid-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223023/

June 15, 2021 Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8205198/

April 26, 2021 Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222):  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107358/

Transient Cardiac Injury

June 2, 2021 Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8443419/

Thymic hyperplasia 

Aug 26, 2021 Thymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8387216/

Uveitis (inflammation of the Uvea)

Sept 30, 2021 Bilateral uveitis after inoculation with COVID-19 vaccine: a case report:  https://www.sciencedirect.com/science/article/pii/S1201971221007797

Variant Inducement

May 2021 Occurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant):  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8555616/

Vogt-Koyanagi-Harada Syndrome 

Aug 30, 2021 Vogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8404022/

July 5, 2021 Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination:  https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8256412/

Wow, these bioweapons sure look safe.
- said no rational human being ever!

Here’s the list of the 1,291 AESI’s that Pfizer tried, in vain, to hide from the world for 75 years..

APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST

IP36 deletion syndrome; 2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa; Acquired epileptic aphasia;Acute cutaneous lupus erythematosus; Acute disseminated encephalomyelitis;Acute encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic dermatosis; Acute flaccid myelitis; Acute haemorrhagic leukoencephalitis; Acute haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy; Acute motor axonal neuropathy; Acute motor-sensory axonal neuropathy; Acute myocardial infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's disease;Administration site thrombosis;Administration site vasculitis; Adrenal thrombosis;Adverse event following immunisation; Ageusia;Agranulocytosis;Air embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic oedema; Alloimmune hepatitis;Alopecia areata; Alpers disease;Alveolar proteinosis; Ammonia abnormal; Ammonia increased;Amniotic cavity infection; Amygdalohippocampectomy; Amyloid arthropathy; Amyloidosis; Amyloidosis senile; Anaphylactic reaction; Anaphylactic shock; Anaphylactic transfusion reaction; Anaphylactoid reaction;Anaphylactoid shock; Anaphylactoid syndrome of pregnancy; Angioedema; Angiopathic neuropathy; Ankylosing spondylitis; Anosmia; Antiacetylcholine receptor antibody positive;Anti-actin antibody positive; Anti-aquaporin-4 antibody positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody positive;Anti-erythrocyte antibody positive; Anti-exosome complex antibody positive; AntiGAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody positive; Antigliadin antibody positive;Anti-glomerular basement membrane antibody positive;Anti-glomerular basement membrane disease; Anti-glycyl-tRNA synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased; Antiinsulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody positive;Anti-islet cell antibody positive; Antimitochondrial antibody positive;Anti-muscle specific kinase antibody positive; Anti-myelin-associated glycoprotein antibodies positive;Anti-myelin-associated glycoprotein associated polyneuropathy; Antimyocardial antibody positive;Anti-neuronal antibody positive; Antineutrophil cytoplasmic antibody increased; Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody positive vasculitis; Anti-NMDA antibody positive;Antinuclear antibody increased; Antinuclear antibody positive; Antiphospholipid antibodies positive; Antiphospholipid syndrome; Anti-platelet antibody positive;Anti-prothrombin antibody positive; Antiribosomal P antibody positive;Anti-RNA polymerase III antibody positive; Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody positive;Anti-SRP antibody positive; Antisynthetase syndrome;Anti-thyroid antibody positive; Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;AntiVGKC antibody positive; Anti-vimentin antibody positive; Antiviral prophylaxis; Antiviral treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic thrombosis; Aortitis; Aplasia pure red cell;Aplastic anaemia; Application site thrombosis;Application site vasculitis; Arrhythmia; Arterial bypass occlusion;Arterial bypass thrombosis; Arterial thrombosis; Arteriovenous fistula thrombosis; Arteriovenous graft site stenosis; Arteriovenous graft thrombosis; Arteritis; Arteritis coronary; Arthralgia; Arthritis; Arthritis enteropathic; Ascites; Aseptic cavernous sinus thrombosis; Aspartate aminotransferase abnormal; Aspartate aminotransferase increased; Aspartate-glutamate-transporter deficiency; AST to platelet ratio index increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID19; Ataxia; Atheroembolism; Atonic seizures;Atrial thrombosis; Atrophic thyroiditis; Atypical benign partial epilepsy; Atypical pneumonia;Aura; Autoantibody positive;Autoimmune anaemia; Autoimmune aplastic anaemia;Autoimmune arthritis; Autoimmune blistering disease; Autoimmune cholangitis ; Autoimmune colitis; Autoimmune demyelinating disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune encephalopathy; Autoimmune endocrine disorder;Autoimmune enteropathy; Autoimmune eye disorder; Autoimmune haemolytic anaemia; Autoimmune heparin-induced thrombocytopenia; Autoimmune hepatitis; Autoimmune hyperlipidaemia; Autoimmune hypothyroidism; Autoimmune inner ear disease; Autoimmune lung disease; Autoimmune lymphoproliferative syndrome; Autoimmune myocarditis; Autoimmune myositis; Autoimmune nephritis;Autoimmune neuropathy; Autoimmune neutropenia; Autoimmune pancreatitis; Autoimmune pancytopenia; Autoimmune pericarditis; Autoimmune retinopathy; Autoimmune thyroid disorder; Autoimmune thyroiditis; Autoimmune uveitis; Autoinflammation with infantile enterocolitis; Autoinflammatory disease; Automatism epileptic; Autonomic nervous system imbalance;Autonomic seizure;Axial spondyloarthritis; Axillary vein thrombosis; Axonal and demyelinating polyneuropathy; Axonal neuropathy; Bacterascites; Baltic myoclonic epilepsy; Band sensation; Basedow's disease; Basilar artery thrombosis; Basophilopenia;B-cell aplasia; Behcet's syndrome;Benign ethnic neutropenia; Benign familial neonatal convulsions;Benign familial pemphigus; Benign rolandic epilepsy;Beta-2 glycoprotein antibody positive; Bickerstaff's encephalitis; Bile output abnormal; Bile output decreased; Biliary ascites; Bilirubin conjugated abnormal; Bilirubin conjugated increased;Bilirubin urine present; Biopsy liver abnormal; Biotinidase deficiency; Birdshot chorioretinopathy; Blood alkaline phosphatase abnormal; Blood alkaline phosphatase increased; Blood bilirubin abnormal; Blood bilirubin increased; Blood bilirubin unconjugated increased; Blood cholinesterase abnormal;Blood cholinesterase decreased; Blood pressure decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe syndrome; Brachiocephalic vein thrombosis;Brain stem embolism; Brain stem thrombosis; Bromosulphthalein test abnormal; Bronchial oedema; Bronchitis;Bronchitis mycoplasmal; Bronchitis viral; Bronchopulmonary aspergillosis allergic; Bronchospasm;BuddChiari syndrome; Bulbar palsy; Butterfly rash;C1q nephropathy; Caesarean section;Calcium embolism; Capillaritis; Caplan's syndrome; Cardiac amyloidosis; Cardiac arrest; Cardiac failure; Cardiac failure acute; Cardiac sarcoidosis; Cardiac ventricular thrombosis; Cardiogenic shock; Cardiolipin antibody positive; Cardiopulmonary failure; Cardio-respiratory arrest; Cardio-respiratory distress; Cardiovascular insufficiency; Carotid arterial embolus; Carotid artery thrombosis; Cataplexy; Catheter site thrombosis; Catheter site vasculitis; Cavernous sinus thrombosis; CDKL5 deficiency disorder; CEC syndrome; Cement embolism; Central nervous system lupus; Central nervous system vasculitis; Cerebellar artery thrombosis; Cerebellar embolism; Cerebral amyloid angiopathy; Cerebral arteritis; Cerebral artery embolism; Cerebral artery thrombosis; Cerebral gas embolism; Cerebral microembolism; Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus thrombosis; Cerebral venous thrombosis; Cerebrospinal thrombotic tamponade; Cerebrovascular accident; Change in seizure presentation; Chest discomfort; ChildPugh-Turcotte score abnormal; Child-Pugh-Turcotte score increased; Chillblains; Choking;Choking sensation; Cholangitis sclerosing; Chronic autoimmune glomerulonephritis; Chronic cutaneous lupus erythematosus; Chronic fatigue syndrome; Chronic gastritis;Chronic inflammatory demyelinating polyradiculoneuropathy; Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids; Chronic recurrent multifocal osteomyelitis; Chronic respiratory failure; Chronic spontaneous urticaria; Circulatory collapse; Circumoral oedema; Circumoral swelling; Clinically isolated syndrome; Clonic convulsion; Coeliac disease; Cogan's syndrome; Cold agglutinins positive; Cold type haemolytic anaemia; Colitis; Colitis erosive; Colitis herpes; Colitis microscopic; Colitis ulcerative; Collagen disorder; Collagen-vascular disease; Complement factor abnormal; Complement factor C1 decreased; Complement factor C2 decreased; Complement factor C3 decreased; Complement factor C4 decreased; Complement factor decreased; Computerised tomogram liver abnormal; Concentric sclerosis; Congenital anomaly; Congenital bilateral perisylvian syndrome; Congenital herpes simplex infection; Congenital myasthenic syndrome; Congenital varicella infection;Congestive hepatopathy; Convulsion in childhood; Convulsions local; Convulsive threshold lowered; Coombs positive haemolytic anaemia; Coronary artery disease; Coronary artery embolism; Coronary artery thrombosis; Coronary bypass thrombosis; Coronavirus infection; Coronavirus test; Coronavirus test negative; Coronavirus test positive; Corpus callosotomy; Cough; Cough variant asthma; COVID-19;COVID-19 immunisation; COVID-19 pneumonia; COVID-19 prophylaxis; COVID-19 treatment; Cranial nerve disorder; Cranial nerve palsies multiple; Cranial nerve paralysis;CREST syndrome; Crohn's disease; Cryofibrinogenaemia; Cryoglobulinaemia; CSF oligoclonal band present ;CSWS syndrome; Cutaneous amyloidosis; Cutaneous lupus erythematosus; Cutaneous sarcoidosis; Cutaneous vasculitis; Cyanosis; Cyclic neutropenia; Cystitis interstitial; Cytokine release syndrome; Cytokine storm; De novo purine synthesis inhibitors associated acute inflammatory syndrome; Death neonatal; Deep vein thrombosis; Deep vein thrombosis postoperative; Deficiency of bile secretion; Deja vu; Demyelinating polyneuropathy; Demyelination; Dermatitis; Dermatitis bullous; Dermatitis herpetiformis; Dermatomyositis; Device embolisation; Device related thrombosis; Diabetes mellitus; Diabetic ketoacidosis; Diabetic mastopathy; Dialysis amyloidosis; Dialysis membrane reaction; Diastolic hypotension; Diffuse vasculitis; Digital pitting scar; Disseminated intravascular coagulation;Disseminated intravascular coagulation in newborn; Disseminated neonatal herpes simplex; Disseminated varicella; Disseminated varicella zoster vaccine virus infection; Disseminated varicella zoster virus infection; DNA antibody positive;Double cortex syndrome; Double stranded DNA antibody positive; Dreamy state; Dressler's syndrome; Drop attacks; Drug withdrawal convulsions; Dyspnoea; Early infantile epileptic encephalopathy with burst-suppression; Eclampsia; Eczema herpeticum; Embolia cutis medicamentosa; Embolic cerebellar infarction; Embolic cerebral infarction; Embolic pneumonia; Embolic stroke; Embolism; Embolism arterial; Embolism venous; Encephalitis; Encephalitis allergic; Encephalitis autoimmune; Encephalitis brain stem; Encephalitis haemorrhagic; Encephalitis periaxialis diffusa; Encephalitis post immunisation; Encephalomyelitis; Encephalopathy; Endocrine disorder; Endocrine ophthalmopathy; Endotracheal intubation; Enteritis; Enteritis leukopenic; Enterobacter pneumonia; Enterocolitis; Enteropathic spondylitis; Eosinopenia;Eosinophilic fasciitis; Eosinophilic granulomatosis with polyangiitis; Eosinophilic oesophagitis; Epidermolysis; Epilepsy; Epilepsy surgery; Epilepsy with myoclonic-atonic seizures;Epileptic aura; Epileptic psychosis;Erythema; Erythema induratum; Erythema multiforme; Erythema nodosum; Evans syndrome; Exanthema subitum; Expanded disability status scale score decreased; Expanded disability status scale score increased; Exposure to communicable disease; Exposure to SARS-CoV-2;Eye oedema; Eye pruritus; Eye swelling; Eyelid oedema; Face oedema; Facial paralysis; Facial paresis; Faciobrachial dystonic seizure; Fat embolism; Febrile convulsion; Febrile infection-related epilepsy syndrome; Febrile neutropenia; Felty's syndrome; Femoral artery embolism; Fibrillary glomerulonephritis; Fibromyalgia; Flushing; Foaming at mouth; Focal cortical resection; Focal dyscognitive seizures; Foetal distress syndrome; Foetal placental thrombosis; Foetor hepaticus; Foreign body embolism; Frontal lobe epilepsy; Fulminant type 1 diabetes mellitus; Galactose elimination capacity test abnormal; Galactose elimination capacity test decreased; Gamma-glutamyltransferase abnormal; Gamma-glutamyltransferase increased; Gastritis herpes; Gastrointestinal amyloidosis; Gelastic seizure; Generalised onset non-motor seizure; Generalised tonic-clonic seizure; Genital herpes; Genital herpes simplex; Genital herpes zoster; Giant cell arteritis; Glomerulonephritis; Glomerulonephritis membranoproliferative; Glomerulonephritis membranous; Glomerulonephritis rapidly progressive; Glossopharyngeal nerve paralysis; Glucose transporter type 1 deficiency syndrome; Glutamate dehydrogenase increased; Glycocholic acid increased;GM2 gangliosidosis; Goodpasture's syndrome; Graft thrombosis; Granulocytopenia; Granulocytopenia neonatal; Granulomatosis with polyangiitis; Granulomatous dermatitis;Grey matter heterotopia; Guanase increased; GuillainBarre syndrome;Haemolytic anaemia; Haemophagocytic lymphohistiocytosis; Haemorrhage;Haemorrhagic ascites; Haemorrhagic disorder; Haemorrhagic pneumonia; Haemorrhagic varicella syndrome; Haemorrhagic vasculitis; Hantavirus pulmonary infection; Hashimoto's encephalopathy; Hashitoxicosis; Hemimegalencephaly; Henoch-Schonlein purpura; Henoch Schonlein purpura nephritis; Hepaplastin abnormal; Hepaplastin decreased; Heparin-induced thrombocytopenia; Hepatic amyloidosis; Hepatic artery embolism; Hepatic artery flow decreased; Hepatic artery thrombosis; Hepatic enzyme abnormal; Hepatic enzyme decreased; Hepatic enzyme increased; Hepatic fibrosis marker abnormal; Hepatic fibrosis marker increased; Hepatic function abnormal; Hepatic hydrothorax; Hepatic hypertrophy; Hepatic hypoperfusion; Hepatic lymphocytic infiltration; Hepatic mass;Hepatic pain;Hepatic sequestration; Hepatic vascular resistance increased; Hepatic vascular thrombosis; Hepatic vein embolism; Hepatic vein thrombosis; Hepatic venous pressure gradient abnormal; Hepatic venous pressure gradient increased; Hepatitis; Hepatobiliary scan abnormal; Hepatomegaly; Hepatosplenomegaly; Hereditary angioedema with C1 esterase inhibitor deficiency; Herpes dermatitis; Herpes gestationis;Herpes oesophagitis; Herpes ophthalmic; Herpes pharyngitis; Herpes sepsis;Herpes simplex; Herpes simplex cervicitis; Herpes simplex colitis; Herpes simplex encephalitis; Herpes simplex gastritis; Herpes simplex hepatitis; Herpes simplex meningitis; Herpes simplex meningoencephalitis; Herpes simplex meningomyelitis; Herpes simplex necrotising retinopathy; Herpes simplex oesophagitis; Herpes simplex otitis externa; Herpes simplex pharyngitis; Herpes simplex pneumonia; Herpes simplex reactivation; Herpes simplex sepsis;Herpes simplex viraemia; Herpes simplex virus conjunctivitis neonatal; Herpes simplex visceral; Herpes virus infection; Herpes zoster; Herpes zoster cutaneous disseminated; Herpes zoster infection neurological; Herpes zoster meningitis; Herpes zoster meningoencephalitis; Herpes zoster meningomyelitis; Herpes zoster meningoradiculitis; Herpes zoster necrotising retinopathy ;Herpes zoster oticus; Herpes zoster pharyngitis;Herpes zoster reactivation; Herpetic radiculopathy; Histone antibody positive; Hoigne's syndrome; Human herpesvirus 6 encephalitis;Human herpesvirus 6 infection; Human herpesvirus 6 infection reactivation; Human herpesvirus 7 infection; Human herpesvirus 8 infection; Hyperammonaemia; Hyperbilirubinaemia; Hypercholia; Hypergammaglobulinaemia benign monoclonal; Hyperglycaemic seizure; Hypersensitivity; Hypersensitivity vasculitis; Hyperthyroidism; Hypertransaminasaemia; Hyperventilation; Hypoalbuminaemia; Hypocalcaemic seizure; Hypogammaglobulinaemia; Hypoglossal nerve paralysis; Hypoglossal nerve paresis ;Hypoglycaemic seizure; Hyponatraemic seizure; Hypotension; Hypotensive crisis; Hypothenar hammer syndrome; Hypothyroidism; Hypoxia;Idiopathic CD4 lymphocytopenia; Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic neutropenia; Idiopathic pulmonary fibrosis; IgA nephropathy; IgM nephropathy; IIIrd nerve paralysis;IIIrd nerve paresis; Iliac artery embolism;Immune thrombocytopenia; Immunemediated adverse reaction; Immune-mediated cholangitis; Immune-mediated cholestasis;Immune-mediated cytopenia; Immune-mediated encephalitis;Immune-mediated encephalopathy; Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immunemediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis; Immunemediated hyperthyroidism; Immune-mediated hypothyroidism; Immune-mediated myocarditis; Immune-mediated myositis;Immune-mediated nephritis; Immune-mediated neuropathy; Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis; Immunoglobulin G4 related disease; Immunoglobulins abnormal; Implant site thrombosis; Inclusion body myositis; Infantile genetic agranulocytosis; Infantile spasms;Infected vasculitis; Infective thrombosis; Inflammation;Inflammatory bowel disease; Infusion site thrombosis; Infusion site vasculitis; Injection site thrombosis; Injection site urticaria;Injection site vasculitis; Instillation site thrombosis; Insulin autoimmune syndrome;I nterstitial granulomatous dermatitis; Interstitial lung disease; Intracardiac mass; Intracardiac thrombus;Intracranial pressure increased; Intrapericardial thrombosis; Intrinsic factor antibody abnormal;Intrinsic factor antibody positive; IPEX syndrome; Irregular breathing; IRVAN syndrome; IVth nerve paralysis ;IVth nerve paresis; JC polyomavirus test positive; JC virus CSF test positive; Jeavons syndrome; Jugular vein embolism;Jugular vein thrombosis; Juvenile idiopathic arthritis;Juvenile myoclonic epilepsy; Juvenile polymyositis; Juvenile psoriatic arthritis; Juvenile spondyloarthritis; Kaposi sarcoma inflammatory cytokine syndrome; Kawasaki's disease; Kayser-Fleischer ring; Keratoderma blenorrhagica;Ketosisprone diabetes mellitus; Kounis syndrome;Lafora's myoclonic epilepsy;Lambl's excrescences; Laryngeal dyspnoea; Laryngeal oedema; Laryngeal rheumatoid arthritis; Laryngospasm; Laryngotracheal oedema;Latent autoimmune diabetes in adults; LE cells present;Lemierre syndrome; Lennox-Gastaut syndrome; Leucine aminopeptidase increased; Leukoencephalomyelitis; Leukoencephalopathy; Leukopenia;Leukopenia neonatal; Lewis-Sumner syndrome; Lhermitte's sign;Lichen planopilaris; Lichen planus; Lichen sclerosus; Limbic encephalitis; Linear IgA disease;Lip oedema; Lip swelling; Liver function test abnormal;Liver function test decreased;Liver function test increased; Liver induration; Liver injury;Liver iron concentration abnormal; Liver iron concentration increased; Liver opacity;Liver palpable;Liver sarcoidosis; Liver scan abnormal;Liver tenderness; Low birth weight baby; Lower respiratory tract herpes infection; Lower respiratory tract infection; Lower respiratory tract infection viral; Lung abscess;Lupoid hepatic cirrhosis; Lupus cystitis;Lupus encephalitis;Lupus endocarditis; Lupus enteritis;Lupus hepatitis; Lupus myocarditis;Lupus myositis; Lupus nephritis;Lupus pancreatitis ;Lupus pleurisy;Lupus pneumonitis;Lupus vasculitis; Lupus-like syndrome; Lymphocytic hypophysitis;Lymphocytopenia neonatal; Lymphopenia; MAGIC syndrome;Magnetic resonance imaging liver abnormal; Magnetic resonance proton density fat fraction measurement; Mahler sign; Manufacturing laboratory analytical testing issue; Manufacturing materials issue;Manufacturing production issue; Marburg's variant multiple sclerosis; Marchiafava-Bignami disease; Marine Lenhart syndrome; Mastocytic enterocolitis; Maternal exposure during pregnancy; Medical device site thrombosis; Medical device site vasculitis; MELAS syndrome; Meningitis; Meningitis aseptic; Meningitis herpes; Meningoencephalitis herpes simplex neonatal; Meningoencephalitis herpetic; Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test positive; Mesangioproliferative glomerulonephritis; Mesenteric artery embolism; Mesenteric artery thrombosis; Mesenteric vein thrombosis; Metapneumovirus infection; Metastatic cutaneous Crohn's disease; Metastatic pulmonary embolism; Microangiopathy;Microembolism;Microscopic polyangiitis; Middle East respiratory syndrome; Migraine-triggered seizure;Miliary pneumonia;Miller Fisher syndrome; Mitochondrial aspartate aminotransferase increased; Mixed connective tissue disease; Model for end stage liver disease score abnormal; Model for end stage liver disease score increased;Molar ratio of total branched-chain amino acid to tyrosine; Molybdenum cofactor deficiency; Monocytopenia; Mononeuritis; Mononeuropathy multiplex;Morphoea; Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal motor neuropathy; Multiple organ dysfunction syndrome;Multiple sclerosis; Multiple sclerosis relapse; Multiple sclerosis relapse prophylaxis; Multiple subpial transection; Multisystem inflammatory syndrome in children; Muscular sarcoidosis;Myasthenia gravis;Myasthenia gravis crisis; Myasthenia gravis neonatal;Myasthenic syndrome; Myelitis; Myelitis transverse; Myocardial infarction; Myocarditis; Myocarditis post infection; Myoclonic epilepsy; Myoclonic epilepsy and ragged-red fibres; Myokymia; Myositis; Narcolepsy; Nasal herpes; Nasal obstruction; Necrotising herpetic retinopathy; Neonatal Crohn's disease; Neonatal epileptic seizure; Neonatal lupus erythematosus; Neonatal mucocutaneous herpes simplex; Neonatal pneumonia; Neonatal seizure; Nephritis; Nephrogenic systemic fibrosis; Neuralgic amyotrophy; Neuritis; Neuritis cranial; Neuromyelitis optica pseudo relapse; Neuromyelitis optica spectrum disorder; Neuromyotonia; Neuronal neuropathy; Neuropathy peripheral; Neuropathy, ataxia, retinitis pigmentosa syndrome;Neuropsychiatric lupus; Neurosarcoidosis; Neutropenia; Neutropenia neonatal; Neutropenic colitis; Neutropenic infection; Neutropenic sepsis; Nodular rash; Nodular vasculitis; Noninfectious myelitis; Noninfective encephalitis; Noninfective encephalomyelitis; Noninfective oophoritis;Obstetrical pulmonary embolism; Occupational exposure to communicable disease; Occupational exposure to SARS-CoV-2; Ocular hyperaemia; Ocular myasthenia; Ocular pemphigoid; Ocular sarcoidosis; Ocular vasculitis; Oculofacial paralysis; Oedema; Oedema blister; Oedema due to hepatic disease; Oedema mouth; Oesophageal achalasia; Ophthalmic artery thrombosis; Ophthalmic herpes simplex; Ophthalmic herpes zoster; Ophthalmic vein thrombosis;Optic neuritis; Optic neuropathy; Optic perineuritis; Oral herpes; Oral lichen planus;Oropharyngeal oedema; Oropharyngeal spasm; Oropharyngeal swelling; Osmotic demyelination syndrome; Ovarian vein thrombosis; Overlap syndrome; Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection; Paget-Schroetter syndrome; Palindromic rheumatism; Palisaded neutrophilic granulomatous dermatitis;Palmoplantar keratoderma; Palpable purpura; Pancreatitis; Panencephalitis; Papillophlebitis; Paracancerous pneumonia;Paradoxical embolism; Parainfluenzae viral laryngotracheobronchitis; Paraneoplastic dermatomyositis; Paraneoplastic pemphigus; Paraneoplastic thrombosis; Paresis cranial nerve; Parietal cell antibody positive; Paroxysmal nocturnal haemoglobinuria; Partial seizures; Partial seizures with secondary generalisation; Patient isolation; Pelvic venous thrombosis; Pemphigoid;Pemphigus; Penile vein thrombosis; Pericarditis; Pericarditis lupus; Perihepatic discomfort; Periorbital oedema; Periorbital swelling; Peripheral artery thrombosis; Peripheral embolism; Peripheral ischaemia;Peripheral vein thrombus extension; Periportal oedema; Peritoneal fluid protein abnormal; Peritoneal fluid protein decreased; Peritoneal fluid protein increased;Peritonitis lupus; Pernicious anaemia; Petit mal epilepsy; Pharyngeal oedema; Pharyngeal swelling; Pityriasis lichenoides et varioliformis acuta; Placenta praevia; Pleuroparenchymal fibroelastosis; Pneumobilia; Pneumonia; Pneumonia adenoviral; Pneumonia cytomegaloviral; Pneumonia herpes viral; Pneumonia influenzal; Pneumonia measles; Pneumonia mycoplasmal;Pneumonia necrotising; Pneumonia parainfluenzae viral; Pneumonia respiratory syncytial viral; Pneumonia viral; POEMS syndrome; Polyarteritis nodosa; Polyarthritis; Polychondritis; Polyglandular autoimmune syndrome type I; Polyglandular autoimmune syndrome type II; Polyglandular autoimmune syndrome type III; Polyglandular disorder; Polymicrogyria; Polymyalgia rheumatica; Polymyositis; Polyneuropathy; Polyneuropathy idiopathic progressive; Portal pyaemia; Portal vein embolism; Portal vein flow decreased;Portal vein pressure increased;Portal vein thrombosis; Portosplenomesenteric venous thrombosis; Post procedural hypotension; Post procedural pneumonia;Post procedural pulmonary embolism; Post stroke epilepsy; Post stroke seizure; Post thrombotic retinopathy; Post thrombotic syndrome; Post viral fatigue syndrome; Postictal headache ;Postictal paralysis; Postictal psychosis; Postictal state; Postoperative respiratory distress; Postoperative respiratory failure; Postoperative thrombosis; Postpartum thrombosis; Postpartum venous thrombosis; Postpericardiotomy syndrome; Post-traumatic epilepsy; Postural orthostatic tachycardia syndrome; Precerebral artery thrombosis; Pre-eclampsia; Preictal state; Premature labour; Premature menopause; Primary amyloidosis; Primary biliary cholangitis; Primary progressive multiple sclerosis; Procedural shock;Proctitis herpes; Proctitis ulcerative; Product availability issue; Product distribution issue; Product supply issue; Progressive facial hemiatrophy; Progressive multifocal leukoencephalopathy; Progressive multiple sclerosis; Progressive relapsing multiple sclerosis; Prosthetic cardiac valve thrombosis; Pruritus; Pruritus allergic; Pseudovasculitis; Psoriasis; Psoriatic arthropathy;Pulmonary amyloidosis; Pulmonary artery thrombosis; Pulmonary embolism; Pulmonary fibrosis; Pulmonary haemorrhage; Pulmonary microemboli; Pulmonary oil microembolism; Pulmonary renal syndrome; Pulmonary sarcoidosis; Pulmonary sepsis; Pulmonary thrombosis; Pulmonary tumour thrombotic microangiopathy; Pulmonary vasculitis; Pulmonary veno-occlusive disease; Pulmonary venous thrombosis; Pyoderma gangrenosum; Pyostomatitis vegetans; Pyrexia; Quarantine; Radiation leukopenia; Radiculitis brachial; Radiologically isolated syndrome; Rash; Rash erythematous; Rash pruritic; Rasmussen encephalitis; Raynaud's phenomenon; Reactive capillary endothelial proliferation; Relapsing multiple sclerosis; Relapsing-remitting multiple sclerosis; Renal amyloidosis; Renal arteritis; Renal artery thrombosis; Renal embolism;Renal failure; Renal vascular thrombosis; Renal vasculitis; Renal vein embolism; Renal vein thrombosis; Respiratory arrest; Respiratory disorder; Respiratory distress;Respiratory failure; Respiratory paralysis; Respiratory syncytial virus bronchiolitis; Respiratory syncytial virus bronchitis; Retinal artery embolism; Retinal artery occlusion; Retinal artery thrombosis; Retinal vascular thrombosis; Retinal vasculitis; Retinal vein occlusion; Retinal vein thrombosis; Retinol binding protein decreased; Retinopathy; Retrograde portal vein flow; Retroperitoneal fibrosis; Reversible airways obstruction; Reynold's syndrome; Rheumatic brain disease; Rheumatic disorder; Rheumatoid arthritis; Rheumatoid factor increased; Rheumatoid factor positive; Rheumatoid factor quantitative increased; Rheumatoid lung; Rheumatoid neutrophilic dermatosis; Rheumatoid nodule; Rheumatoid nodule removal; Rheumatoid scleritis; Rheumatoid vasculitis; Saccadic eye movement ;SAPHO syndrome; Sarcoidosis; SARS-CoV-1 test; SARS-CoV-1 test negative; SARS-CoV-1 test positive; SARS-CoV-2 antibody test; SARS-CoV-2 antibody test negative; SARS-CoV-2 antibody test positive; SARS-CoV-2 carrier; SARS-CoV-2 sepsis; SARS-CoV-2 test;S ARSCoV-2 test false negative; SARS-CoV-2 test false positive; SARS-CoV-2 test negative; SARSCoV-2 test positive; SARS-CoV-2 viraemia; Satoyoshi syndrome; Schizencephaly; Scleritis; Sclerodactylia; Scleroderma; Scleroderma associated digital ulcer; Scleroderma renal crisis; Scleroderma-like reaction; Secondary amyloidosis; Secondary cerebellar degeneration; Secondary progressive multiple sclerosis; Segmented hyalinising vasculitis; Seizure; Seizure anoxic;Seizure cluster; Seizure like phenomena; Seizure prophylaxis; Sensation of foreign body;Septic embolus; Septic pulmonary embolism; Severe acute respiratory syndrome; Severe myoclonic epilepsy of infancy; Shock; Shock symptom; Shrinking lung syndrome; Shunt thrombosis; Silent thyroiditis; Simple partial seizures; Sjogren's syndrome; Skin swelling; SLE arthritis; Smooth muscle antibody positive; Sneezing; Spinal artery embolism; Spinal artery thrombosis; Splenic artery thrombosis; Splenic embolism; Splenic thrombosis; Splenic vein thrombosis; Spondylitis; Spondyloarthropathy; Spontaneous heparin-induced thrombocytopenia syndrome; Status epilepticus; Stevens-Johnson syndrome; Stiff leg syndrome; Stiff person syndrome; Stillbirth;Still's disease; Stoma site thrombosis; Stoma site vasculitis; Stress cardiomyopathy; Stridor; Subacute cutaneous lupus erythematosus; Subacute endocarditis; Subacute inflammatory demyelinating polyneuropathy; Subclavian artery embolism; Subclavian artery thrombosis; Subclavian vein thrombosis; Sudden unexplained death in epilepsy; Superior sagittal sinus thrombosis; Susac's syndrome; Suspected COVID19; Swelling; Swelling face; Swelling of eyelid; Swollen tongue; Sympathetic ophthalmia; Systemic lupus erythematosus; Systemic lupus erythematosus disease activity index abnormal; Systemic lupus erythematosus disease activity index decreased; Systemic lupus erythematosus disease activity index increased; Systemic lupus erythematosus rash;Systemic scleroderma; Systemic sclerosis pulmonary; Tachycardia; Tachypnoea; Takayasu's arteritis; Temporal lobe epilepsy; Terminal ileitis ;Testicular autoimmunity; Throat tightness; Thromboangiitis obliterans; Thrombocytopenia; Thrombocytopenic purpura; Thrombophlebitis; Thrombophlebitis migrans; Thrombophlebitis neonatal; Thrombophlebitis septic; Thrombophlebitis superficial; Thromboplastin antibody positive; Thrombosis; Thrombosis corpora cavernosa; Thrombosis in device; Thrombosis mesenteric vessel; Thrombotic cerebral infarction; Thrombotic microangiopathy; Thrombotic stroke; Thrombotic thrombocytopenic purpura; Thyroid disorder; Thyroid stimulating immunoglobulin increased; Thyroiditis; Tongue amyloidosis; Tongue biting;Tongue oedema; Tonic clonic movements; Tonic convulsion; Tonic posturing; Topectomy; Total bile acids increased; Toxic epidermal necrolysis; Toxic leukoencephalopathy; Toxic oil syndrome; Tracheal obstruction; Tracheal oedema; Tracheobronchitis; Tracheobronchitis mycoplasmal; Tracheobronchitis viral; Transaminases abnormal; Transaminases increased; Transfusion-related alloimmune neutropenia; Transient epileptic amnesia; Transverse sinus thrombosis; Trigeminal nerve paresis; Trigeminal neuralgia; Trigeminal palsy; Truncus coeliacus thrombosis; Tuberous sclerosis complex; Tubulointerstitial nephritis and uveitis syndrome; Tumefactive multiple sclerosis; Tumour embolism; Tumour thrombosis; Type 1 diabetes mellitus; Type I hypersensitivity; Type III immune complex mediated reaction; Uhthoff's phenomenon; Ulcerative keratitis; Ultrasound liver abnormal; Umbilical cord thrombosis; Uncinate fits; Undifferentiated connective tissue disease; Upper airway obstruction; Urine bilirubin increased; Urobilinogen urine decreased; Urobilinogen urine increased; Urticaria; Urticaria papular; Urticarial vasculitis; Uterine rupture; Uveitis; Vaccination site thrombosis; Vaccination site vasculitis; Vagus nerve paralysis; Varicella; Varicella keratitis; Varicella post vaccine; Varicella zoster gastritis; Varicella zoster oesophagitis; Varicella zoster pneumonia; Varicella zoster sepsis; Varicella zoster virus infection; Vasa praevia; Vascular graft thrombosis; Vascular pseudoaneurysm thrombosis; Vascular purpura; Vascular stent thrombosis;Vasculitic rash;Vasculitic ulcer; Vasculitis; Vasculitis gastrointestinal; Vasculitis necrotising; Vena cava embolism; Vena cava thrombosis; Venous intravasation; Venous recanalisation; Venous thrombosis; Venous thrombosis in pregnancy; Venous thrombosis limb; Venous thrombosis neonatal; Vertebral artery thrombosis; Vessel puncture site thrombosis; Visceral venous thrombosis; VIth nerve paralysis; VIth nerve paresis; Vitiligo; Vocal cord paralysis;Vocal cord paresis; Vogt-Koyanagi-Harada disease; Warm type haemolytic anaemia; Wheezing; White nipple sign; XIth nerve paralysis; X-ray hepatobiliary abnormal; Young's syndrome; Zika virus associated Guillain Barre syndrome.”

To all “health authorities” who have the cajoles to read this, I tried to warn you but this is what happens when you opted to deem me “non-essential”..

Feel free to share this and my other research with those who still have their heads buried in the sand. Maybe, just maybe, this will wake them from their slumber.

Thanks for reading and if you find any mistakes or find new studies or categories before I do? Add them in the comments below and I will update.

Remember,

I am not “anti-vaccine”, I am “anti-unsafe medical procedures of ANY KIND!”